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1. Introduction 
Augmentation cystoplasty is performed to increase bladder capacity  and compliance. The 
primary use of augmentation cystoplasty is to protect renal function, to achieve urinary 
continence, and often to facilitate urinary tract reconstruction (1). The most common 
problems necessitating bladder augmentation are neurogenic bladder dysfunction 
secondary to myelodysplasia, extrophy of the bladder, and posterior urethral valves. 
However, many other conditions may require bladder augmentation including tuberculosis, 
interstitial cystitis, multiple surgeries, chemotherapy and radiation therapy. 
Not all patients undergoing augmentation cystoplasty, especially in the pediatric 
population, can achieve complete emptying of their bladder by spontaneous voiding. It was 
the success and wide spread acceptance of clean intermittent catheterization (CIC) in the 
mid-1970s that made augmentation cystoplasty and continent urinary diversion possible 
especially in children (2). 
Conventional enterocystoplasty employs the use of detubularized segments of small or large 
bowel. Ileum, sigmoid and cecum have all been used; several studies have confirmed the 
reliability of these segments (3, 4). 
Despite the functional success of enterocystoplasty, clinical experience has demonstrated 
that there are numerous complications that can result from the incorporation of small and 
large bowel and their heterotropic epithelium into the urinary tract. To avoid some of the 
deleterious side effects of enterocystoplasty, several procedures have been developed to 
augment the bladder without the use of the bowel. These include gastrocystoplasty, the use 
of dilated ureter (either naturally dilated or balloon dilated), autoaugmentation and 
seromuscular enterocystoplasty (5, 6, 7, 8, 9).  
Autoaugmentation involves the excision of the detrusor muscle from the dome of the 
bladder allowing the epithelium to form a large diverticulum which may or may not be 
covered with a seromuscular gastric or sigmoid patch as a backing. In addition, recent 
advances in tissue engineering substrates and biomaterials have enhanced our abilities to 
possibly regenerate bladder tissue that is clinically useful for augmentation purposes. 
Generally, three classes of biomaterials have been used for engineering of genitourinary 
tissues; naturally derived materials, such as collagen and alginate, cellular tissue matrices 
such as bladder and small intestinal submucosa (SIS) and synthetic polymers such as 
polyglycolic acid (PGA) and polylactic acid (PLA) (10, 11, 12, 13). 
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At this time, even so, there are significant potential problems with the use intestinal 
segments in the lower urinary tract; gastrointestinal (GI) segments remain the gold standard 
for increasing bladder capacity and improving compliance. These problems include:  
hyperchloremic metabolic acidosis, hyokalemia, hypocalcemia, ammoniagenic 
encephalopathy, bone demineralization, vitamin B12 deficiency, malabsorption, drug 
absorption toxicities, growth retardation, mucus secretion, urinary tract infection, urinary 
calculi and tumor formation. Gastrocystoplasty may be complicated with hypochloremic 
metabolic alkalosis and hematuria-dysuria syndrome (14). 
Therefore augmentation cystoplasty should be offered only after medical intervention such 
as anticholinergic medications and intermittent catheterization fail to achieve dryness or to 
improve bladder compliance sufficiently.  
The majority of children who undergo augmentation cystoplasty will require intermittent 
catheterization (1). The commitment and capacity of both child and the family to comply 
with catheterization must be assessed carefully. All potential complications should be 
discussed in details with adult patients and with the family of the child. 
Conditions that may require bladder augmentation 
 
Neurogenic Bladder  
   Myelodysplasia  
   Sacral agenesis  
   Caudal regression  
   Spinal tumors, vascular malformation  
   Myelitis  
   Idiopathic  
 
Congenital  
   Exstrophy (cloacal, classic, epispadias)  
   Posterior urethral valves  
 
Cloaca  
   Urogenital sinus  
   Bilateral single ectopic ureters  
   Infantile bladder syndrome  
   Ureterocele  
   Prune-belly syndrome  
 
Other  
   Infection (tuberculosis, viral cystitis, bacterial cystitis)  
   Interstitial cystitis  
   Iatrogenic (multiple surgeries)  
   Chemotherapy  
   Radiation therapy  
   Tumor (rhabdomyosarcoma, neurofibromatosis)  
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2. Augmentation cystoplasty using bowel segments (enteroplasty) 
2.1 General principles 
The initial approach to augmentation cystoplasty is similar regardless of the bowel segments 
to be used. Cystoscopy should be performed preoperatively to avoid any unsuspected 
anatomic abnormalities that may affect the surgery. In augmentation cystoplasty, the two 
critical aspects of the surgery are the preparation of the bladder and the augmentation 
segment chosen. 
2.2 Preparation of the native bladder 
In augmentation cystoplasty, the bladder usually is addressed first. Most commonly, a 
midline incision is used to expose the abdomen & pelvis. If possible, the peritoneum is not 
entered until the bladder has been prepared for augmentation and other associated 
procedures such as ureteral reimplantation or bladder neck reconstruction have been 
performed. This minimizes third space fluid loss. The bladder is then bivalved through a 
sagittal incision from near the bladder neck anteriorly to near the trigone posteriorly, thus 
forming a "clam-shell" configuration. This maneuver is extremely important because the 
bladder must be opened fully to prevent the augmentation segment from acting as a 
diverticulum with the formation of an "hour-glass" deformity. Such an incision allows a 
technically easier anastomosis of the bowel segment and leaves the native bladder wings to 
add to the overall capacity. The bladder wings may also be used for implantation of a 
continent catheterizable channel (e.g. Mitrofanoff) or ureteral reimplantation. 
Supratrigonal cystectomy is generally not recommended. The remaining cuff of the bladder 
is a relatively small area for anastomosis to the intestinal segment; therefore most of the 
bowel is approximated to itself which could result in the augmentation segment behaving as 
a diverticulum (1,15). Nevertheless, other surgeons have recommended that the majority of 
the "diseased" bladder be excised in preparation for augmentation. A greater circumference 
for the anastomosis can sometimes be provided by opening the bladder in a stellate fashion 
with a second transverse incision into the two bladder halves (15). 
 
 
The dysfunctional bladder is opened in the sagittal plane from the bladder neck to the 
trigone (1). 
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2.3 Harvesting the augmentation segment 
The size and configuration of the augmentation segment are probably more important than 
the type of bowel used.  
Hinman (1988) and Koff (1988) have clearly demonstrated the advantages of opening bowel 
segments on their antimesenteric border, thereby allowing detubularization and 
reconfiguration of these segments. Detubularization and reconfiguration maximizes the 
added surface area to the bladder and thus the benefit of a given segment. Furthermore, the 
intrinsic innervation is disrupted and peristalsis is decreased significantly (16, 17). 
Reconfiguration into a spherical shape provides multiple advantages that improve the 
overall capacity and compliance. Spherical configuration, by geometry, maximizes the 
volume achieved for a given bladder wall area. In addition, the spherical configuration also 
maximizes the radius of curvature, thereby increasing surface tension for a given bladder 
pressure, which tends to lead to further bladder expansion. This is the relationship of 
Laplace's law (T = k RP), where T is wall tension, k is a constant dependant on elasticity and 
wall characteristics, R is the radius of curvature, and P is the luminal pressure. 
 
 
Calculated capacity of 40-cm segment opened and folded twice is 665 mL. C, circumference; 
d, diameter; h, height; r, radius; V, volume. (From Hinman F Jr. Selection of intestinal 
segments for bladder substitution: physiological characteristics. J Urol 1988;139:521)  
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The length of the segment used depends on: a)  the radius of the bowel used; therefore a 
larger segment of small bowel usually is required; b) patient's age; c)the size of the pelvis; d) 
the volume of the native bladder being augmented; if the cystoplasty is being done on a 
bladder of moderate volume that generates high pressure by uninhibited contractions, less 
bowel is necessary than for a bladder that is tiny in capacity; e) patient's urinary volumes; 
patients with upper tract damage, particularly with concentrating ability, may make huge 
volumes of urine and require a larger capacity. 
Depending on the volume needed, 15 to 40 cm of ileum and approximately 20 cm of colon is 
usually used for cystoplasty. If a segment of stomach is to be used as the augmentation 
segment, a wedge of at least one-third of the stomach is harvested (19). The gastric wedge 
requires no reconfiguration as it fits well onto the bivalved bladder. If the ureter is to be 
used as an augmentation segment, there must be significant dilation and it should likewise 
be detubularized before being anastomosed to the bladder (20). 
The choice of the augmentation segment needs to be tailored individually to each patient. 
For example, patients with a short ileal mesentery may require the use of the sigmoid to 
allow for a tension-free anastomosis. Patients with a short gut, renal insufficiency, or a 
history of pelvic radiation may be better served with a gastrocystoplasty. Patients with 
myelomeningocele or imperforate anus theoretically could develop diarrhea if the ileocecal 
valve is taken from their gastrointestinal (GI) tract (21, 22). Other factors to consider include 
the need for ureteral reimplantation and the need for a continent catheterizable channel. 
Therefore, it is important to consider each patient individually when selecting the 
appropriate augmentation segment. 
 
Cystoplasty Mean Mean Mean 
Mean 
Value 
First 
Contraction 
Max. 
Contraction 
  
 
Age 
(yr) 
F/U 
(mo) 
Cap 
(mL) 
At 300 
mL cm 
H2O 
Mean Vol 
(mL) 
Mean P cm 
H2O 
Mean 
Vol 
(mL) 
Mean 
P cm 
H2O 
Tubular right 
colon  
17.5 9.7 630 18.6 139 37 467 63 
Detubularized 
right colon  
28.5 5.1 641 9.4 329 24 596 42 
Tubular ileum  66.8 7.0 311 36 110 60 218 81 
Detubularized 
ileum  
20.0 5.7 403 14.4 197 22 265 28 
From Goldwasser B, et al. Cystometric properties of ileum and right colon after bladder augmentation, 
substitution or replacement. J Urol 1997; 138(2):1007. 
Effect of detubularization of colon and ileum on cystoplasty compliance and contraction 
3. Types and techniques of enterocystoplasty 
3.1 Ileocystoplasty  
3.1.1 Technical considerations 
Goodwin and colleagues (1959) were among the first to demonstrate the numerous ways of 
anastomosing a patch of ileum to the native bladder. Virtually all surgeons recognize that 
ileum should be detubularized and reconfigured to achieve the most spherical shape 
possible (Q.15). 
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A segment of ileum at least 15 to 20 cm proximal to the ileocecal valve should be selected. 
The distal portion of terminal ileum is unique from a physiologic standpoint and should be 
avoided. The isolated segment should be 15 to 40 cm in length, depending on patient's size, 
native bladder capacity,  type of reconfiguration  and desired final capacity. With short 
ureters, an extra tail of isoperistaltic ileum can be useful to reach the foreshortened ureters. 
This requires creation of an ileonipple valve to prevent reflux, as in the Kock or hemi-Kock 
pouch. This type of construction may require up to 60 cm of small intestine.  
The segment to be used should have an adequate mesentery to reach the native bladder 
without tension. After selecting the appropriate segment, the mesentery is cleared from the 
bowel at either end for a short distance to create a window. The bowel is divided at these 
ends, and a handsewn ileoileostomy or stapled anastomosis performed. The harvested ileal 
segment is irrigated clear with 0.25% neomycin solution and opened on its antimesenteric 
border. The ileum is most commonly folded in a U shape, although longer segments can be 
folded further into an S or W configuration. The ileum is then anastomosed to itself with 
running absorbable sutures.  The suture line should approximate the full thickness of ileum 
to ileum while inverting the mucosa. If not opened previously, the bladder is incised in a 
sagittal plane. The anastomosis of the ileum to the native bivalved bladder is easily done 
when started posteriorly.  The anastomosis may be done in a one-or two-layer fashion, 
always with absorbable suture. Permanent suture should never be used for any cystoplasty 
because it may serve as a nidus for stone formation. The mesenteric window at the bowel 
anastomosis is closed to prevent internal herniation.   
 
 
A: 15-40 cm segment of ileum proximal to the ileocecal valve is isolated and an ileoileostomy 
is performed. B: The isolated segment of ileum is opened along the antimesenteric border. 
The opened segment is then folded and the edges are sutured together. C: The opened 
segment is reconfigured to increase the surface volume. D: The reconfigured ileum is 
anastomosed to the opened bladder beginning at the posterior apex (1). 
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Ileum does not allow for standard reimplantation of the ureters or the creation of a continent 
catheterizable channel (i.e., Mitrofanoff), but newer techniques such as the seromuscular 
trough, as described by Abol-Enein and Ghoneim (22) do allow the use of ileum, should these 
procedures be required.  However, because of its muscle backing, native bladder (or a 
gastric flap) is still the primary choice for ureteral reimplantation or the construction of a 
Mitrofanoff valve.   
Although the jejunum can be used for urinary reconstruction, yet the high incidence of 
metabolic complications (hyponatremic, hypochloremic and hyperkalemic acidosis) 
associated with use of this segment make it less desirable and thus rarely used.  
 
 
The seromuscular trough formed by anastomosing the edges of the ileum together allows 
for nonrefluxing ureteral reimplantation into the ileum (22). 
3.1.2 Advantages 
Ileum is the most commonly used bowel segment for bladder augmentation, as it is:'1) 
available in large quantity, 2) ease in handling and reconfiguration, 3) has a predictable and 
abundant blood supply, 4) most compliant segment of bowel, 5) produces moderate mucus 
compared to colon, 6) causes less severe metabolic complications than colon or stomach, 7) 
has fewer GI complications than cecum,  
3.1.3 Disadvantages 
The disadvantages in using ileum include: 1) occasional short mesentery that cannot reach 
the pelvis, 2) possible development of diarrhea and vitamin B12 deficiency, 3) difficulty with 
creation of submucosal tunnels, 4) hyperchloremic, hypokalemic melabolic acidosis, 5) 
bowel obstruction, 6) stone formation, 7) mucus production, 8) urinary tract infections, 9) 
tumor formation which is a risk with large bowel segments as well (14). 
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3.2 Sigmoid cystoplasty  
3.2.1 Technical considerations 
Use of the sigmoid colon for augmentation cystoplasty was first reported by Lemoine in 
1912 (Q.15) and until nowadays continues to be used commonly.  
Because of the strong unit contractions of the sigmoid, it is imperative to detubularize and 
reconfigure the segment used to provide maximal compliance and disruption of 
contractions. Fifteen to 20 cm of sigmoid colon is identified and mobilized. Its mesentery is 
transilluminated to identify the vascular arcade, after which the surgeon must ensure that 
the segment can reach the bladder without tension. If so, the bowel segment is divided 
between clamps and a colocolostomy perfomed. Detubularization and reconfiguration is 
done in a fashion determined by the surgeon's preference. The sigmoid patch is 
anastomosed to the bivalved bladder.  
Sigmoid colon segments are usually reconfigured in one of two ways. Mitchell (1986) 
suggested closing the two ends and then opening the segment longitudinally opposite its 
blood supply (23). The segment easily fits on the bivalved bladder. The bowel segment may 
fit better in either the sagittal or the coronal plane. More radical reconfiguration, and 
perhaps breakup of unit contractions, may be achieved by folding the sigmoid segment in a 
U-Shape. 
 
 
A: A segment of the sigmoid is resected and bowel continuity is reestablished. B: The 
isolated segment of sigmoid is opened on its antimesenteric border and then reconfigured 
before being anastomosed to the bladder (4). 
3.2.2 Advantages 
The major advantage of the use of sigmoid colon is the redundancy that is present especially 
in the spina bifida population. The mobile portion of the sigmoid is so redundant in these 
children that it often lays in the right lower quadrant. It can be easily opened and 
reconfigured into a U-shape to increase compliance. The thicker muscle can be used for an 
antirefluxing ureteral anastomosis as well as for placement of a tunneled continent 
catheterizable. 
3.2.3 Disadvantages 
The major disadvantage of the use of the sigmoid colon is the lessened ability to create a large 
capacity, compliant reservoir. The diameter of the sigmoid may be only similar to the ileum. In 
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certain circumstance, at least a 20 to 30 cm segment of colon is required to create a large 
enough reservoir. This amount of sigmoid colon can occasionally be difficult to obtain in the 
non-spina bifida population. In the Indiana series, the highest spontaneous perforation rate 
occurred among those with sigmoid cystoplasties (19). However, this has not been observed in 
other large series. Finally hyperchloremic acidosis is more common when the sigmoid colon is 
employed, compared to other bowel segments.  Frequently, these patients will need lifelong 
alkalinizing agents but this can also be true after ceco or ileocystoplasty as well (24). 
3.3 Cecocystoplasty and ileocecocystoplasty 
3.3.1 Technical considerations 
Couvelair described the use of the cecum for augmentation cystoplasty in 1950 (Q.15). 
Numerous reports of simple cecocystoplasty have appeared since then. Presently, 
cecocystoplasty is an uncommon operative procedure; it has largely been replaced by 
various forms of ileocecocystoplasty.  
With the ileocecocystoplasty technique, the cecum is opened, reconfigured, and used to 
augment the bladder alone, leaving a segment of ileum to reach the ureters or to create a 
continent abdominal wall stoma based on imbrication of the ileocecal valve and proximal 
ileum. Conversely, the ileal segment can be opened and used as a patch on the cecal 
segment before augmentation cystoplasty.  Many modifications of the technique exist, but 
all start with mobilization of the cecum and right colon by incising the peritoneum along the 
white line of Toldt up to the hepatic flexure. Approximately 15 to 30 cm of the terminal 
ileum is used. The length of the ileal segment depends on the technique employed. As with 
all intestinal cystoplasties, before division of the bowel segment, it should be certain that it 
will reach the bladder without tension.  
The isolated ileocecal segment is irrigated clear with neomycin solution and opened on its 
antimesenteric border through the ileocecal valve for its entire length. In the typical ileocecal 
augmentation, the ileal and cecal segments are of equivalent length such that the borders of 
the open segment can be anastomosed and then folded on themselves to form a cup 
cystoplasty. The anastomosis of the reconfigured segments is done in a one-or two-layer 
closure with absorbable suture. The opening should be left large enough to provide a wide 
anastomosis to the bivalved bladder. If more volume is necessary, the ileal segment can be 
significantly lenghtened, allowing it to be folded before anastomosis to the cecum. The 
Mainz ileocystoplasty uses an ileal segment twice the length of the cecal segment. The 
opened edge of the cecal portion is anastomosed to the first portion of the ileal segment. The 
first and second portions of the ileal segment are next approximated. The compound 
ileocecal patch is then anastomosed to the bladder.  
The ileocecal segment has been used extensively for reconstruction and bladder replacement 
in the adult population. It has been used less frequently in children because most of the 
patients undergoing augmentation cystoplasty are doing so because of neurovesical 
dysfunction. Those patients usually have neuropraxic bowel dysfunction as well. Removal 
of the ileocecal valve in such children can result in intractable diarrhea (24, 25). Use of the 
ileocecal valve in such patients should be avoided unless other advantages of the segment 
outweigh the risk of diarrhea and fecal incontinence.  
3.3.2 Advantages 
One potential advantage of ileocecocystoplasy is the presence of the appendix. Particularly 
in children, the appendix is useful in the creation of a reliable continent abdominal wall  
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Ileocecocystoplasty. A). An ileocecal segment is selected. The length of segment chosen 
depends on the technique employed. After removal, it is opened on the antimesenteric 
border (dashed lines). B). The opened ileal and cecal segments are anastomosed to form a cup 
in the standard ileocecocystoplasty (15). 
stoma. The appendix may be removed with a small cuff of cecal wall and tunneled into the 
native bladder or a tenia of the cecal segment to provide a continent mechanism.  Likewise, 
it may be left in situ and the base safely tunneled by creating a window in the 
mesoappendix. If the appendix is not to be used, an appendectomy is performed with the 
standard ileocecocystoplasy. 
There are further advantages to the use of the ileocecal segment. Antireflux tunnels can 
easily be made into the tenia of the cecum when necessary. Again, for the short ureter, a tail 
of ileum can be left intact to bridge the gap, with the imbricated ileocecal valve used for 
antireflux. The same imbrication technique can be used to create a continent abdominal wall 
stoma as with the appendix. Cain and Husmann (1994) and Cain et al (1999) have proposed 
using the ileocecal segment for augmentation with the plicated ileal segment brought to the 
abdominal wall as a catheterizable stoma, as in the Indiana pouch (26,27). Another major 
advantage of these segments is the use of a portion of bowel that has a large diameter 
resulting in a capacious and compliant reservoir that often fits the bladder base rather 
nicely. It also has a well-defined reliable blood supply.  
3.3.3 Disadvantages  
The major disadvantage to the use of the ileocecal segment is related to the loss of the 
ilieocecal valve. Patients with neurologic disorders or short gut often have an increased 
incidence of diarrhea and difficulty with fecal continence. In addition, this segment is not 
available in the cloacal exstrophy population who has little to no hindgut. The ileocecal 
segment also reabsorbs urinary wastes which may result in hyperchloremic acidosis. Finally, 
cecum usually produces more mucus than the ileum which can lead to increased infections 
and stone formation. 
3.3.4 Summary 
Through the early 1980s, the cecum and sigmoid colon were more commonly used than 
ileum for enterocystoplasy. However, because of the shorter mesenteries, increased mucus 
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production, and difficulty with configuration that is associated with large bowel, ileum has 
come to be the preferred segment of bowel for enterocystopasty for most surgeons. 
However, detubulairzed large bowel is still used for simple bladder augmentation in select 
patients (14).            
3.4 Gastrocystoplasty  
3.4.1 Technical considerations 
Two basic techniques exist for the use of stomach in bladder augmentation. Leong and Ong 
(1972) described the use of the entire gastric antrum with a small rim of body for bladder 
replacement. With their technique, the left gastroepiploic artery is always used as a vascular 
pedicle. If the right gastroepiploic artery is dominant and the left vessel ends high on the 
greater curvature, a strip of body along the greater curvature from the left gastroepiploic ar-
tery to the antrum is maintained and provides adequate blood supply. Continuity of the 
upper gastrointestinal tract is restored by a Billroth I gastroduodenostomy (28).   
In the second type of gastrocystoplasly, a gastric wedge based on the midportion of the greater 
curvature is used (29).   The gastric segment used in this technique is made up mainly of body 
and consequently has a higher concentration of acid-producing cells. The right or left 
gastroepiploic artery may be used as a vascular pedicle to this segment. The right artery is 
commonly dominant and therefore is more frequently used. The wedge-shaped segment of 
stomach includes both anterior and posterior wall. The segment used may be 10 to 20 cm 
along the greater curvature, depending on patient age and size as well as the needed volume. 
The incision into the stomach is stopped just short of the lesser curvature to avoid injury to 
branches of the vagus nerve that control the gastric outlet. Branches of the left gastric artery 
just cephalad to the apex of this incision are suture ligated in situ before incision to avoid 
significant bleeding. Parallel atraumatic bowel clamps are placed on either side of the gastric 
incisions to avoid excessive bleeding or spillage of gastric contents. Alternatively, the 
stomach may be incised using a gastrointestinal stapling device that places a double row of 
staples, on each side of the incision (30). The staple lines, however, must be excised. The 
native stomach is closed in two layers using permanent sutures on the outer seromuscular 
layer. 
The short gastric branches of the gastroepiploic artery to the antrum on the right or to the 
high corpus on the left are divided to provide mobilization of the gastroepiploic pedicle 
leaving the short gastric branches to the augmentation segment intact. In order that the 
eventual pedicle would be long enough to reach the bladder, the appropriate segment may 
be higher on the greater curvature if the right vessel is used as a pedicle, or lower if based 
on the left.  
The vascular pedicle, with omentum, should not be free-floating through the abdomen. The 
segment and pedicle may be passed through windows in the transverse mesocolon and 
mesentery of the distal ileum and carefully secured to the posterior peritoneum. Despite 
careful consideration for an adequate pedicle length, on occasion the gastric segment 
initially does not reach the bladder without tension. Either gastroepiploic artery may be 
mobilized closer to its origin for further length. The first few branches from the 
gastroepiploic artery to the isolated gastric segment may also be divided. Because of the rich 
submucosal arterial plexus in the stomach, devascularization of the isolated segment does 
not result. Rarely, it may be necessary to approximate some of the isolated gastric segment 
to itself in one corner. The gastric segment should be approximated to the native bladder 
www.intechopen.com
 Understanding the Complexities of Kidney Transplantation 
 
290 
with one or two layers of absorbable sutures, taking care to invert the mucosa. Usually the 
gastric wedge fits well with the bivalved bladder.   
Raz and colleagues (1993) have described the use of a much longer, narrower segment of 
stomach based along the greater curvature. Use of this segment, which includes both body 
and antrum, somewhat narrows the lumen of the stomach in its entire length except at the 
fundus and pylorus (31) Raz and colleagues (1993) isolated this segment with the use of a 
gastrointestinal stapler so that the native stomach was never open. Histamine 2 receptor 
blockers are often given in the early postoperative period to promote healing (31).  
 
 
A). A wedge from the body of the stomach is harvested with a stapling device. B). The 
gastric wedge usually is based on the blood supply from the right gastroepiploic vessel. C). 
The gastric wedge is brought through the transverse colon and small bowel mesentery to 
reach the bladder. D). The gastric wedge is sutured to the bladder in two layers (1). 
3.4.2 Patient selection for gastrocystoplasty 
The stomach is unique with special physiologic and metabolic properties. Given the specific 
advantages and disadvantages that gastric segments exhibit in comparison to intestinal 
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segments, gastrocystoplasty appears to be most appropriate for patients with renal 
insufficiency and for those with short intestines, as well as in patients with cloacal 
exstrophy. Also since the development of the hematuria dysuria syndrome is fairly common 
following gastrocystoplasty, this type of augmentation is most appropriate in patients who 
have minimal or no perineal and urethral sensation. If gastrocystoplasty is performed in 
patients that are sensate, it is important to ensure that patients are completely continent. 
Caution should be exercised when considering gastrocystoplasty in a patient with end stage 
renal disease in need of transplantation since ulcer formation and perforation of 
defunctionalized bladders have been reported (32). In general, patients that fulfill the 
preoperative criteria for conventional enterocystoplasty can also be considered candidates 
for gastrocystoplasty. 
3.4.3 Advantages 
Surgically, the stomach is relatively thick and easy to work with. It is readily accessible and 
has a rich reliable vascular supply. The suppleness of the stomach and the well-defined 
submucosal plane makes it ideal for reimplantation of ureters and continent catheterizable 
stomas. Use of stomach for bladder augmentation has clear advantages in patients with 
renal insufficiency due to its ability to secrete acid. This allows for buffering of systemic 
acidosis and lessens the need for bicarbonate supplementation. The resultant acid urine also 
appears to decrease the incidence of bacteriuria.  
In comparison to other intestinal segments, there is also decreased mucus production and 
stone formation. The inherent musculature of the gastric segment may also offer an 
additional advantage over small and large bowel in more often allowing for spontaneous 
voiding that can result in more efficient emptying, less residual urine, and decreased need 
for intermittent catheterization. (33, 34). Lastly both gastrocystoplasty and ileocystoplasty can 
be accomplished laparoscopically which offers significant advantages in more rapid patient 
recovery following surgery (35). 
3.4.4 Disadvantages  
The main disadvantage of gastrocystoplasty that currently limits its widespread use in 
children with a neuropathic bladder is the high incidence of hematuria dysuria syndrome. 
This is most troublesome in patients that have a sensate urethra and perineum. Caution 
should be exercised in selecting patients who are sensate and are at risk for incontinence (i.e. 
bladder exstrophy) when other enteric segments are available. 
3.4.5 Results 
The urodynamic results of gastrocystoplasty are somewhat variable. Most authors report 
that it is useful in increasing capacity and compliance similar to large and small bowel (36). In 
studies that have analyzed both pre- and postoperative urodynamics, gastrocystoplasty has 
been shown to increase bladder capacity by approximately 150 to 200 percent (37, 38). 
However it should be noted that there is a wide range of results reported with regard to 
increased bladder capacity following gastrocystoplasty. In a recent series comparing the 
urodynamic findings and clinical outcomes following augmentation with stomach versus 
intestine, it was shown that both stomach and intestine are efficacious in improving 
compliance but that the use of ileum and colon results in a higher volume reservoir. 
Intestinal segments appear to expand more readily following augmentation than the 
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stomach (39). Some of the differences in the literature regarding improvements in capacity 
and compliance following gastrocystoplasty may be in part explained by variable amounts 
of stomach that are harvested in individual patients. However, less volume expansion seems 
inherent to gastric segments compared to ileum and colon. 
3.4.6 Summary 
Gastrocystoplasty is a useful procedure in the management of children with a neuropathic 
bladder. However, it has unique properties and potential complications from those seen 
with conventional enterocystoplasty. From the available experience, it appears that 
gastrocystoplasty is best suited for patients with renal insufficiency and metabolic acidosis, 
patients with a small amount of bowel available for augmentation, and patients with an 
insensate urethra and perineum. Despite some of the metabolic and physiologic advantages 
of gastrocystoplasty, potential disadvantages still make ileum the preferred intestinal 
segment for the majority of patients undergoing enterocystoplasty at this time (14). 
 
3.5 Overall results of gastro-intestinal augmentation cystoplasty 
The effect of cystoplasty on the patient should be considered in two main categories. First, 
the effect of removal of a relatively small portion of the gastrointestinal tract for use in 
urinary reconstruction must be considered. Any more than rare development of 
gastrointestinal problems would be prohibitive, even if the results were perfect from the 
standpoint of the urinary bladder. Second the effect of augmentation cystoplasty on the 
urinary bladder must be reviewed. The primary goal of augmentation is to provide a 
compliant urinary reservoir. Therefore the main consideration after augmentation is the 
storage pressure and capacity that are achieved. Any other effect in the urinary bladder is a 
side effect or complication that exists because bowel is not a perfect physiologic substitute 
for native bladder. 
 
3.5.1 Bladder compliance after augmentation 
An early lesson of past clinical experience with augmentation cystoplasty is the value of 
detubularization and reconfiguration of the bowel segment (16, 17). Bowel in its native, tubular 
form continues to display peristalsis or mass contraction. The tubular form does not 
maximize the volume achieved for the surface area of bowel used. Hinman (1988) 
demonstrated with a mathematical model that the maximum volume achieved for a given 
surface area occurs when a sphere is created. No finished cystoplasty is a perfect sphere but, 
it should approach that shape as nearly as possible (16).  
Many patients who historically underwent augmentation cystoplasty with a tubular 
segment of bowel have done well, but there have also been numerous failures caused by 
continued pressure in the bladder from the segment left in its native form. Some surgeons 
with extensive experience in augmentation cystoplasty and continent diversion have con-
cluded that ileum is superior to other segments in terms of compliance after augmentation 
(40, 41, 42).Rare reports have suggested superior results with colon compared to ileum. These 
reports have involved longer colonic segments that were reconfigured in a U shape. Good 
results have been achieved with all segments in most cases, and it is more important to use a 
bowel segment well than to choose a particular bowel segment for every patient. 
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Lytton and Green (1989) demonstrated mass contractions generating pressures of 60 to 110 
cm H2O in right colon reservoirs despite detubularization (44). Such pressures approach 
those observed in native cecum (45). Hedlund and coworkers (1984) reported pressures of 
only 25 cm H2O in detubularized cecal segments 1 year after reconstruction (46). Placement of 
an ileal patch on a cecal segment can be a more effective mean of decreasing mass 
contractions than simple reconfiguration (47).  
Sidi and associates (1986) demonstrated early peak bladder pressures of 41 cm H2O after 
cup-patch sigmoid cystoplasty that improved with time (48). Goldwasser's review of 
enterocystoplasty using detubularized ileum and colon demonstrated contractions greater 
than 15 cm H2O in 42% of patients after ileocystoplasty, compared with, 60% after 
colocystoplasty(18). Significant contractions, defined as those greater than 40 cm H2O at a 
volume of less than 200 ml, were not noted in any of the ileal augmentations but did persist 
in 10% of cecal cystoplasties. In continent urinary diversion, ileal reservoirs have been noted 
to have lower basal pressures and less motor activity (24). Cecal reservoirs have been noted to 
generate more pressure per given volume than ileum despite detubularization and to 
exhibit more obvious uninhibited contractions (49).  
Any problems with pressure after augmentation cystoplasty usually occur because of 
uninhibited contractions, apparently in the bowel segment. It is extremely rare not to 
achieve an adequate capacity or flat tonus limb unless a technical error has occurred with 
use of the bowel segment. Occasionally, a small, scarred pelvis prevents adequate expansion 
of the augmented bladder. When pressure contractions occur in the bladder after 
augmentation, they are often noted on a rhythmic or sinusoidal pattern, occasionally with 
increasing amplitude (15).  
For most patients, the pressure contractions noted urodynamically are of theoretical interest 
only and have not affected the clinical result. Contractions that begin at low amplitude later 
in filling and progress only near capacity may be of no clinical significance at all. Early 
contractions of higher pressure may occasionally result in persistent incontinence, delayed 
perforation, hydronephrosis, or vesicoureteral reflux. If patients have such clinical problems 
after augmentation, repeat urodynamic testing is necessary.  
One cannot assume that the bladder is compliant after augmentation. Rhythmic contractions 
have been noted postoperatively with all bowel segments, although ileum seems the least 
likely to demonstrate remarkable urodynamic abnormalities, and stomach the most. 
Rhythmic contractions after cystoplasty have been noted in up to 62% of patients (39, 50). The 
segment of stomach initially described for augmentation using the body was much smaller 
in size than segments of ileum or colon commonly used for cystoplasty. The use of a slightly 
larger gastric segment that is longer along the greater curvature results in improved 
urodynamics after augmentation, with less prominent contractions (38, 50). The antral segment 
of stomach is less likely to demonstrate such contractions (33).  
In perhaps the largest experience with pediatric bladder augmentation, Rink and associates 
(1995) at Indiana University found that approximately 5% of several hundred patients had 
significant uninhibited contractions after augmentation cystoplasty causing clinical 
problems. Rink (1995) found that 6% of more than 300 patients required secondary 
augmentation of a previously augmented bladder for similar problems in long-term follow-
up (51). These secondary augmentations represent true failures of the primary cystoplasty, 
not from any side effect or complication but from failure to achieve the objective capacity 
and compliance. In that series, sigmoid colon, followed by stomach and then ileum, was 
most likely to require reaugmentation. It should be noted that a colonic segment closed at 
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the ends and not generally reconfigured otherwise was typically used in that experience. 
Other studies have suggested that stomach is more likely than colon to require secondary 
intervention (39).    
  
Bowel Segment Advantages Disadvantages 
Stomach  
1. Previous radiation, short gut 
2. Prevents systemic acidosis, 
salt retention 
3. Facilitates tunnels for 
continence and antireflux 
4. Reduces infection 
5. May potentiate growth in 
children 
1. Acid secretion salt loss, 
metabolic alkylosis 
2. Hematuria-dysuria 
syndrome 
3. More difficult to use 
Jejunum  
1. Few, not recommended 1. Salt and water loss, 
metabolic acidosis 
Small Bowel  
1. Availability 
2. Good compliance 
3. Less mucus 
1. Metabolic acidosis salt 
resorption 
2. Loss of resorption surface 
in GI tract (B12, folate) 
3. Sometimes difficult to 
work with (no tunnels) 
Cecum  
1. Availability 
2. Good compliance 
3. Potential for tunnels and 
use of IC valve 
1. Metabolic acidosis, salt 
and water resorption 
2. Loss of IC valve may 
cause diarrhea 
Sigmoid  
1. Most available 
2. Good compliance 
3. Potential for tunnels 
1. Not available in some 
patients (radiation, 
constipation) 
2. Metabolic acidosis, salt 
and water resorption 
3. Possible increased 
potential for rupture 
GI, gastrointestinal. 
Advantages and disadvantages of specific bowel segments (1) 
4. Complications of gastrointestinal cystoplasty 
4.1 Complications of bowel segment Isolation 
4.1.1 Postoperative bowel obstruction  
Postoperative bowel obstruction is uncommon after augmentation cystoplasty, occurring in 
approximately 3% of patients. The rate of obstruction is equivalent to that noted after 
conduit diversion or continent urinary diversion (51, 52). Delicate handling of tissues, closure 
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of mesenteric windows, and elimination of sites of internal herniation help to avoid 
obstruction. The incidence of bowel obstruction is low regardless of the gastrointestinal 
segment used and should not influence the choice of a particular segment for 
enterocystoplasty (15). 
4.1.2 Malabsorption abnormalities and diarrhea 
Loss of the distal ileum may result in fat malabsorption and decrease bile salt and fat soluble 
vitamin absorption. The distal ileum and ileocecal valve are important for reabsorption and 
regulation of bowel function. When fecal losses of bile acids exceed production from the 
liver, fat malabsorption occurs. Steatorrhea then occurs with possible impaired absorption of 
lipids and fat soluble vitamins (A, D, E & K). 
The diarrhea associated with bile acid irritation of the colon can be severe. The secretary 
diarrhea is secondary to unabsorbed bile salts, causing active secretion of chloride and water 
in the colon. Reports of chronic diarrhea after bladder augmentation alone have been rare. 
Diarrhea can occur after removal of large segments of ileum from the gastrointestinal tract 
even with the preservation of the ileocecal valve (more than 100 cm). Although the length of 
the segments typically used for augmentation rarely are problematic unless other problems 
coexist (53, 54). The use of a typical colonic segment for augmentation only rarely results in a 
change in bowel function and is less of a risk than the use of ileum.  
Removal of a segment from the gastrointestinal tract that includes the ileocecal valve is the 
most likely procedure to cause diarrhea. Patients with neurogenic dysfunction have 
significant diarrhea after such displacement. Roth et al (1995) reported that 23% of patients 
in their experience had chronic diarrhea after ileocecal urinary diversion and 11% when 
ileum alone was used (53). Some children with neurogenic impairment depend on controlled 
constipation for fecal continence. Removal of the ileocecal valve from the gastrointestinal 
tract may significantly decrease bowel transit time. Loss of the valve can also allow bacterial 
backflow into the ileum, and the organisms may interfere with metabolism of fat and 
vitamin B12. 
Oral cholestyramine and a low fat diet can be used to treat the diarrhea. Diarrhea as a result 
of ileocecal valve resection with decreased transit time can be managed with codeine or 
lomotil. Some authors reported higher incidence of hypertriglyceridemia and gall stones (54).  
4.1.3 Vitamin B12 deficiency  
When portions of the alimentary tract are used for urinary reconstruction, nutritional 
deficiencies can occur. Resection of the terminal ileum can result in vitamin B12 deficiency. 
Vitamin B 12 (cyanocobalamin) cannot be synthesized by human tissues, so humans must 
receive their vitamin B12 supply from dietary sources. In the stomach, vitamin B 12 is 
released from food by hydrochloric acid and digestive enzymes. Intrinsic factor binds to 
vitamin B12 in the duodenum, and then attaches to receptors in the distal ileum. Vitamin 
B12 is then stored in the liver and supplies last up to three years. 
Deficiency of vitamin B12 causes a megaloblastic anemia and neurologic changes including 
peripheral neuropathies, optic atrophy, degenerative changes of the spinal cord, and 
dementia in the late stages (54). Several reports in the literature describe patients in whom the 
terminal ileum is resected for urinary diversion with a 3.3 to 20 percent incidence of vitamin 
B12 deficiency (55). Fifty centimeters of ileum appear to be the critical length, with larger 
resections of small bowel placing the patient at risk for vitamin deficiency (56). Neurological 
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symptoms may occur before serum levels are depressed and without megaloblastic anemia. 
Pannek and associates recommend starting therapy with 100 mcg of hydroxycobalamin 
injected intramuscularly monthly one year after surgery for patients losing more than 50cm 
of terminal ileum (56). 
4.2 Metabolic complications of gastrointestinal augmentation cystoplasty 
To understand the potential complications of gastrointestinal cystoplasty, one must take into 
account many factors. These factors include the length and the type of intestinal segment, 
the general health of the patient, the time urine is in contact with bowel mucosa, and the 
basic underlying renal and hepatic function.  
Serum electrolyte abnormalities are dependent upon the segment of bowel used. Other 
factors include the constituents of urine in the augmented bladder which depend on many 
factors including fluid intake, diet and intercurrent illness, gastroenteritis, and dehydration 
(57). 
4.2.1 Hyperchloremic metabolic acidosis 
Ileum and colon have similar solute transport properties. Normal urine has higher 
potassium and hydrogen ion concentration and a lower sodium concentration than normal 
intestinal contents. 
Hydrogen ions in the urine must be excreted with a buffer. As a patient becomes acidotic, 
the kidneys initially excrete acid buffered with phosphates or sulfates, or titratable acids. As 
the acidosis becomes chronic however, the kidney generates ammonia (NH3) from the 
conversion of glutamine to alpha-ketoglutarate. Ammonia buffers the free hydrogen ion and 
becomes ammonium, NH4+. Ileal and colonic mucosa will therefore secrete sodium and bi-
carbonate and absorb hydrogen, chloride, and ammonium upon exposure to urine, resulting 
in the development of a hyperchloremic metabolic acidosis (57). Patients with good 
underlying renal function can overcome this acid reabsorption by excreting even more 
urinary acid. 
The majority of the acid load following augmentation cystoplasty is the result of the net 
ammonium absorption. Ammonia, ionized ammonium and chloride are absorbed when 
ileum or colon is exposed to urine, and the majority of the acid load is from the absorbed 
ammonium chloride. Ammonium and hydrogen are then transported with chloride to 
maintain electric neutrality (58).  
In 1987, Mitchell and Piser noted that essentially every patient after augmentation with an 
intestinal segment had an increase in serum chloride and a decrease in serum bicarbonate 
level, although full acidosis was rare if renal function was normal (4). Mild metabolic 
acidosis is found in 15 percent of patients with ileal conduit diversions. As many as ten 
percent of patients with ileal conduits require therapy for persistent acidosis. Similarly, 10 to 
15 percent of patients with colon conduits develop acidosis. Due to increased urine contact 
time, metabolic acidosis after bladder replacement with ileum is found in 50 percent of 
cases. Over 50 percent of colonic reservoirs also have some degree of hyperchloremic 
metabolic acidosis. Initial reports of ureterosigmoidostomy patients indicate that they have 
as much as an 80 percent incidence of metabolic acidosis. The risk of acidosis also appears to 
correlate directly with length of bowel used (54, 59).  
The absorptive properties of the intestinal segment may diminish over time. Histological 
changes occur, including mucosal atrophy and decreased villous height. These histologic 
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findings are believed to cause a reduced absorptive capacity of bowel, however, other 
studies demonstrate no change in absorptive capacity of the intestinal segment despite 
histological changes (60). Most likely, the majority of individuals with metabolic 
derangement do not develop significant changes in electrolyte transport to protect them 
from untoward complications. 
Patients may present with signs and symptoms of fatigue, diarrhea, weight loss, anorexia, 
and polydipsia. Laboratory studies demonstrate a significant non-anion gap acidosis with 
hyperchloremia and azotemia. Arterial blood gases values are more sensitive than serum 
bicarbonate or chloride levels for detection and early management of acidosis (61). 
Acute management includes prompt drainage with treatment of any underlying urinary 
tract infection and correction of any electrolyte abnormalities. Treatment of mild and 
chronic forms of metabolic acidosis involves the use of alkalizing agents. Sodium 
bicarbonate and sodium citrate are useful in restoring acid-base balance. They, however, 
have untoward side effects, with sodium bicarbonate producing considerable gas and 
sodium citrate being very distasteful. To neutralize the acid load, supplementation of 1 -2 
mEq kg/day of alkali is usually sufficient. In patients with refractory hyperchloremic 
metabolic acidosis, and those who cannot tolerate or have a contraindication to the 
alkalizing agents, chlorpromazine has been used successfully in an adult patient with 
refractory metabolic acidosis. Chlorpromazine and nicotinic acid inhibit cyclic adenosine 
monophosphate and thereby inhibit chloride transport and absorption in canine models (62). 
The usefulness of these agents in humans has not been clinically validated. 
4.2.2 Hypokalemia  
Hypokalemia can occur in patients with augmentation cysloplasty. The depletion of potassium 
stores is likely due to the renal wasting of potassium and the chronic metabolic acidosis which 
causes intracellular potassium depletion. Compared to colon, ileal segments have been shown 
to have a greater ability to reabsorb potassium when exposed to high concentrations of the ion 
in urine. Chronic diarrhea may be also a contributing factor for hypokalemia.  
The treatment is exogenous potassium replacement. Once the acidosis is corrected, there 
will be an influx of potassium into the cell because of the extracellular potassium shift. This 
can lead to profound hypokalemia if not recognized and treated promptly.  
4.2.3 Hypocalcemia / Hypomagnesemia 
Hypocalcemia and hypomagnesemia are uncommon complication of augmentation 
cysloplasty. Chronic metabolic acidosis causes loss of calcium from several mechanisms. 
Symptoms include tetany, tremors and irritability. Treatment consists of calcium 
replacement either enterally or parenterally depending on the severity. Hypomagnesemia, 
however uncommon, is due to malabsorption, renal loss, and decreased renal tubular 
absorption with acidosis. Symptoms are similar to hypocalcemia and the treatment again is 
exogenous replacement (57). 
4.2.4 Ammioniagenic encephalopathy 
Urinary ammonium excreted by the kidneys is reabsorbed by the intestinal segment, and 
then returned to the liver via the portal circulation. The liver metabolizes ammonium to 
urea via the ornithine cycle. The liver usually adapts to the excess ammonia in the portal 
circulation without difficulty and rapidly metabolizes it. In the setting of hepatic 
www.intechopen.com
 Understanding the Complexities of Kidney Transplantation 
 
298 
dysfunction, the hepatic reserve for ammonium metabolism may be exceeded, resulting in 
the rare complication of ammoniogenic coma. The syndrome also has been described in 
patients with normal hepatic function (63).  
Systemic bacteremia, with endotoxin production, inhibits hepatic function and may 
precipitate this clinical entity. Urinary tract infections with urea-splitting organisms may 
also overload the ability of the liver to clear the ammonia. If this syndrome occurs in a 
patient suspected of having normal hepatic function, systemic bacteremia or obstruction of 
urinary drainage should be suspected. 
Good urinary drainage and treatment of the offending urinary pathogens usually prevents 
development of the syndrome. Treatment consists of prompt drainage with a Foley catheter. 
Systemic antibiotics treat the possible underlying infection, and neomycin or lactulose is 
given to reduce absorption of ammonia in the gastrointestinal tract (54). 
4.2.5 Bone disease and retarded growth 
A potential long-term complication of intestinal diversion is bone demineralization. This 
clinical entity was initially found in children developing rickets after ureterosigmoidostomy, 
but has also been noted in adults with osteomalacia following ureterosigmoi-dostomy, ileal 
replacement of ureters, and coloplasty (64). In rickets and osteomalacia, bone mineral loss is 
replaced with osteoid resulting in decreased bone strength. Fortunately, severe defects in 
bony demineralization are not common. 
The cause of bone demineralization appears complex and multi-factorial, with changes in 
acid-base balance being the major contributing factor. In chronic acidosis, bone serves to 
buffer the excess acids. Bone minerals released into the circulation, including carbonate and 
phosphate, buffer the hydrogen ions, decreasing the axial skeleton calcium content. 
Systemic acidosis also appears to inhibit the conversionof of 25 hydroxycholecalciferol to 
1,25 dihydroxycholecalciferol and appears to activate osteoclasts producing further bone 
resorption. Additionally, patients with urinary diversions have increased excretion of 
calcium and sulfate. Sulfate has been shown to cause increased excretion of calcium by the 
kidneys. The effect of sulfate is potentiated by acidosis. Chronic metabolic acidosis therefore 
results in negative calcium and phosphate balances (65). 
Changes in acid-base status may be subtle with patients displaying only a minimal decrease 
or normal serum calcium and magnesium level and mild depression of serum bicarbonate 
level. Most patients who present are asymptomatic; however, they may have occult bone 
mineral defects that place the patient at higher risk for increased orthopedic morbidity. 
The diagnosis can be particularly difficult to detect. Parathormone and vitamin D levels are 
typically normal, and radiologic examination is usually unremarkable. Post-menopausal 
women and children are at high risk for bone demineralization with several studies showing 
a reduction in growth potential for children following enterocystoplasty. 
Patients presenting with rickets or osteomalacia should have correction of their acid-base 
disturbance first. Vitamin D and calcium supplements are then used if remineralization does 
not occur. Administration of vitamin C or oral alkalizing agents to children with urinary 
diversion may help reinforce normal bone development and prevent bone destruction (66). 
4.2.6 Drug absorption toxicities 
Absorption of drugs excreted in urine from bowel segments can cause toxicities. One must 
be aware of the potential toxicities that can result from absorption of active drug such as 
methotrexate or metabolites in patients with augmentation cystoplasty (54).  
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4.2.7 Hypochloremic alkalosis 
Significant metabolic derangement can occur with gastric diversions. In contrast to ileum or 
colonic cystoplasty the stomach excretes chloride. This can lead to profound hypochloremic, 
hypokalemic alkalosis. It has been proposed that the alkalosis results from ongoing chloride 
loss from the gastric segment in the bladder in the face of decreased oral intake. The 
decreased ability to excrete bicarbonate from an impaired kidney may compound the 
problem. Gosalbez and associates (1993) demonstrated persistently increased traditional 
excretion of chloride despite profound hypochloremia, suggesting that inappropriate gastric 
secretion is probably the primary problem (39).           
Patients may present with lethargy, mental status changes, intractable seizures, and 
respiratory compromise related to a compensatory respiratory acidosis (39). Patients are 
prone to suffer from severe dehydration secondary to a loss of fluid, chloride, and 
potassium from the gastric segment. A simple viral gastroenteritis illness may trigger severe 
symptoms of dehydration and alkalosis. 
Replacement with normal saline and correction of serum potassium abnormalities usually 
corrects the metabolic abnormalities. Patients should maintain good oral and normal salt 
intake. Additional oral salt and potassium supplementation may be needed. Histamine-2 
blockers and anticholinergic therapy may also be needed in patients with low-grade 
alkalosis. Refractory episodes of hypokalemic, hypochloremic metabolic alkalosis may be 
treated with inhibiting K+/H+ exchange with such agents as omeprazole.  
4.2.8 Hematuria-dysuria syndrome 
Acid secretion by gastric mucosa may result in another unique problem after 
gastrocystoplasty, the hematuria-dysuria syndrome. Virtually all patients with normal 
sensation after gastrocystoplasty have occasional hematuria or dysuria with voiding or 
catheterization beyond that which is expected with other intestinal segments. All patients 
should be warned of this potential problem, although in most the symptoms are intermittent 
and mild and do not require treatment. Avoidance of gastrocystoplasty in patients with 
bladder exstrophy is recommended. The dysuria is certainly not a problem in patients with 
neurogenic dysfunction.  
In the experience of Nguyen and coworkers (1993), 36% of patients developed signs or 
symptoms of the hematuria-dysuria syndrome after gastrocystoplasty; 14% required 
treatment with medications, 9% on a regular basis. They believed that patients who are 
incontinent or have decreased renal function are at increased risk (67). The symptoms of the 
hematuria-dysuria syndrome respond well to administration of H2 blockers and hydrogen 
ion pump blockers. Bladder irrigation with baking soda may also be effective. It has been 
demonstrated that urinary pH may decrease remarkably after meals in those who have 
undergone gastrocystoplasty.  
The signs and symptoms of the hematuria-dysuria syndrome are most likely secondary to 
acid irritation. Acid in urine may cause external irritation and skin excoriation. Recent work 
has suggested that Helicobacter pylori may play a role in this complication, as it may increase 
acid complications in the native stomach (68). Such problems are less frequent after antral 
cystoplasty, where there is a smaller load of parietal cells. 
4.2.9 Mucus production 
Intestinal segments continue to produce mucus after placement in the urinary tract. The 
proteinaceous material can potentially impede bladder drainage during voiding or CIC, 
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particularly in pediatric patients who must use small-caliber catheters. Mucus may serve as 
a nidus for infection or stone formation when it remains in the bladder for long periods. 
Mucus production often increases after cystoplasty in the presence of cystitis. Colonic seg-
ments produce more mucus than ileum and gastric segments produce the least amount. 
Most patients do not require any routine bladder irrigations for mucus after 
gastrocystoplasty. Villous atrophy in the ileum has been documented after long-term 
placement in the urinary tract. It has been suggested that such atrophy may result in 
decreased mucus production 
Hendren and Hendren (1990) noted a decrease in mucus production from colonic segments 
over years (3), however, others have not been impressed with such changes (51). Glandular 
atrophy in colonic mucosa has not been noted histologically. Routine use of daily bladder 
irrigations to prevent mucus build up may minimize complications of enterocystoplasty 
such as urinary tract infection and calculi. 
4.2.10 Urinary tract infection  
Bacteriuria is very common after intestinal cystoplasty, particularly among patients 
requiring CIC. Recent experience with bowel neobladders has demonstrated that patients 
who are able to spontaneously void to completion frequently maintain sterile urine. It 
appears that the use of CIC is a prominent factor in the development of bacteriuria after 
augmentation cystoplasty; regardless of the segment considered (3, 25).  
Bacteriuria has been noted even when patients are maintained on daily oral antibiotics or 
antibiotic irrigation. Persistent or recurrent bacteriuria occurs in 50% of patients augmented 
with sigmoid colon, compared with 25% of those undergoing ileocystoplasty. Recurrent 
episodes of symptomatic cystitis requiring treatment occurred in 23% of patients after 
cecocystoplasty, 17% after sigmoid cystoplasty, 13% after cecocystoplasty and 8% after 
gastrocystoplasty. Febrile attacks occurred in 13% (51).  
Not every episode of asymptomatic bacteriuria requires treatment in patients performing 
CIC. Bacteriuria should be treated for significant symptoms such as incontinence or 
suprapubic pain and perhaps for hematuria, foul-smelling urine, or remarkably increased 
mucus production. Bacteriuria should be treated if the urine culture demonstrates growth of 
a urea-splitting organism that may lead to stone formation.  
4.2.11 Calculus disease  
Patients with augmentation cystoplasty are at risk for upper and lower urinary tract 
calculus disease. These patients are chronically dehydrated from water loss through the 
diversion producing concentrated urine which may be a nidus for stone disease. 
Additionally urinary stasis, mucous production from the intestinal segment and frequent 
colonization with urea-spitting organisms places the patient at risk (3). Patients in whom 
large segments of ileum have been removed may develop enteric hyperoxaluria which 
places the patient at risk for calcium oxalate stone formation. Hypocitraturia a risk factor for 
stone disease may be found in patient with chronic metabolic acidosis and malabsorption 
abnormalities. Hypercalciuria is a result of the acidosis, and can lead to mobilization of 
calcium from bone and impaired reabsorption from acid renal tubule fluid.  
Several series reported calculi in 18% of patients after augmentation cystoplasty (3, 43). 
Patients catheterizing through an abdominal wall stoma had the highest risk, probably 
because of incomplete emptying. Palmer and associates (1993) noted urolithiasis in 52% of 
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patients after augmentation cystoplasty. Rink and colleagues (1995) noted only an 8% rate of 
bladder stone formation in 231 patients with long-term follow-up after enterocystoplasty (51). 
The reasons for these remarkable differences are not clear. Stones have been noted after the 
use of all intestinal segments, with no significant difference noted between small and large 
intestine. Struvite stones are less likely after gastrocystoplasty probably because of 
decreased mucus production and acid that minimizes bacteriuria. Uric acid calculi have 
rarely been noted in the bladder after gastrocystoplasty (37). 
Patients should be instructed to keep adequately hydrated. Staples and nonabsorbable 
sutures should be avoided in the urinary diversion. Infection with urea-splitting organisms 
should be treated promptly. Patients should be instructed in the importance of regular 
reservoir catheterizing. Irrigation may be needed if one produces excessive amounts of 
mucous. Foods high in oxalate should be avoided in patients with enteric hyperoxaluria. 
Calcium citrate may be given to bind oxalate in the gut reducing its absorption. A low fat 
diet may reduce calcium saponification and increase the amount of calcium available to bind 
oxalate. 
4.3 Long-term complications 
4.3.1 Tumor formation  
A well recognized complication of ureterosigmoidostomy has been the development of 
tumors, primarily adenocarcinoma, at the ureterocolonic anastomotic site. The latency for 
development of such tumors averaged 26 years and ranged from 3 to 53 years. 
Adenocarcinomas were the prominent tumors that developed, but benign polyps and other 
types of carcinoma were also found (15). The exact basis for the increased risk is unknown; 
however, N-nitroso compounds thought to originate from a mixture of urine and faces may 
be carcinogenic. These compounds have been noted in the urine of patients with conduit 
diversion and augmentation (69). Husmann and Spence (1990) suggested that those 
compounds are more likely enhancing agents rather than a lone cause for tumor 
development. 
It has been proposed that inflammatory reaction at the anastomotic site may induce growth 
factor production, which, in turn, increases cellular proliferation (68). Filmer and Spencer 
(1990) identified 14 patients who developed adenocarcinoma in an augmented bladder, and 
several more have been reported since then. Nine of those tumors occurred after 
ileocystoplasty and five after colocystoplasty (70).  
Experimental work in the rat demonstrated hyperplastic growth in the augmented bladder 
with all intestinal segments, with no segment showing any particularly increased risk (71). 
The applicability of such findings to humans is uncertain. The long latency period noted for 
tumor development after ureterosigmoidostomy suggests that short-term follow-up after 
augmentation cystoplasty is not adequate to evaluate tumor formation.  
Patients undergoing augmentation cystoplasty should be made aware of a potentially 
increased risk for tumor development. Yearly surveillance of the augmented bladder with 
endoscopy should eventually be performed; the latency period until such procedures are 
necessary is not well defined. The earliest reported tumor after augmentation was found 
only 4 years after cystoplasty (72). Transitional cell carcinoma, hyperplasia, and dysplasia 
have also been noted near the anastomoses in humans. Urine cytology or flow cystometry 
may ultimately become useful in surveillance (73).  
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4.3.2 Delayed spontaneous bladder perforation  
Perhaps the most disturbing complication of augmentation cystoplasty is delayed bladder 
perforation. Patients presenting with spontaneous perforation after augmentation 
cystoplasty are usually quite ill with abdominal pain, distention and fever. Sepsis has been 
common. Nausea, decreased urine output, and shoulder pain from diaphragmatic irritation 
have also been noted. Perforations have been found in the evaluation of virtually 
asymptomatic pelvic masses Patients with neurogenic dysfunction often have impaired 
lower abdominal sensation and present later in the course of the illness; severe sepsis and 
death have occurred. Patients with perforation after gastrocystoplasty often present 
promptly because of acid irritation.  
A high index of suspicion for perforation is necessary. Contrast cystography is diagnostic in most 
cases. Thorough technique is important to identify as many true-positive cases as possible 
with cystography. Some reports of perforations have noted a significant false-negative rate 
on cystography and suggested that ultrasonography and CT improve diagnostic accuracy. 
They recommended that one of those studies be done in any child with suspected perfora-
tion if the initial cystogram is negative (74, 75).    
The cause of delayed perforations within a bowel segment is unknown. It has been 
suggested that perforation might be secondary to traumatic catheterization in some cases. It 
seems unlikely that catheterization trauma is the lone cause in most patients. The location of 
the perforations has been variable among patients and even in a single patient with multiple 
perforations. Perforations have occurred after augmentation in patients who did not 
catheterize at all. Others have suggested that trauma to the bowel caused by fixed adhesions 
that result in sheering forces with emptying and filling may result in perforation (15). 
Chronic, transmural infection of the bladder wall has also been proposed as a cause. 
Histologic examination of bowel segments adjacent to areas of perforation has revealed 
necrosis, vascular congestion, hemorrhage, and hemosiderin deposition compatible with 
chronic bowel wall ischemia. Chronic overdistention of the bladder might result in such 
ischemia. Chronic ischemia may thus play a significant role in at least some delayed bladder 
perforations.  
Pope and associates (1998) reported perforations occurring in bladders with significant 
uninhibited contractions after augmentation. High outflow resistance may maintain bladder 
pressure rather than allowing urinary leakage and venting of the pressure, potentially 
increasing ischemia. Hyperreflexia alone is unlikely as a solitary cause of perforation, 
because the complication was essentially never recognized in the era before bowel 
detubularization and reconfiguration, when persistent pressure contractions were more 
common after augmentation cystoplasty. Once bowel is reconfigured, however, it may be 
more prone to ischemia if high pressure does persist. 
Once spontaneous perforation has occurred, the chance of recurrence is significant. One 
third of patients with rupture in one series had a recurrence (74). Consideration must 
eventually be given to removal of the original segment and replacement by another after 
repeated perforation. 
This problem has been noted with increasing frequency after augmentation cystoplasty and 
may involve all segments. There may be no particular increased risk of one intestinal 
segment over another. With the inconsistent differences across multiple large series, it is 
unlikely that any given enteric segment is at significantly increased risk for perforation and 
probable that multiple factors influence the risk for the complication (15, 20, 48). 
www.intechopen.com
 Augmentation Cystoplasty: in Pretransplant Recepients 
 
303 
The standard treatment for spontaneous perforation of the augmented bladder is surgical 
repair, as it is for intraperitoneal rupture of the bladder after trauma. There are reported 
series of conservative management for suspected perforation consisting of catheter drainage, 
antibiotics and serial abdominal examinations. It was successful in 87% of patients, although 
only 2 of 13 patients with suspected rupture had x-ray documentation unequivocally 
identifying a perforation (74). Even patients who do well with conservative management 
during the acute episode often require surgical intervention eventually. Such management 
may be a consideration in a stable patient with sterile urine. The surgeon should certainly 
have a low threshold for surgical exploration and repair.  
 
 
Problem  Stomach  Ileum  Colon  
Segment 
loss from  
GI tract  
1. Early satiety  
2. Decreased stomach-
acid production  
3. Increased gastrin 
production  
1. Decreased 
absorption of B12, 
folate, and iron  
2. Short-gut 
syndrome  
1. Diarrhea  
2. Water loss  
Acid–base 
balance  
1. Alkalosis  
2. Hematuria/dysuria  
1. Chronic 
metabolic acidosis  
2. Ammonium and 
chloride resorption  
1. Acidosis  
2. Bicarbonate loss  
3. Ammonium 
chloride resorption  
Salt 
balance  
1. Sodium and 
potassium loss  
1. Sodium and 
chloride resorption  
1. Sodium and 
chloride resorption  
Mucus  1. More soluble, less 
apparent  
1. Problem with 
catheter 
obstruction, 
irrigation 
necessary  
1. Problem with 
catheter obstruction, 
irrigation necessary  
Stone 
formation  
1. Rare problem (low 
pH)  
1. Can be a major 
problem, 
irrigations 
recommended  
1. Can be a major 
problem, irrigations 
recommended  
Infection  1. Moderate  1. Common  1. Common  
Tumor  1. None documented 
but too early to tell  
1. Reported  1. Significant in 
ureterosigmoidostomy  
Perforation  1. Reported with 
potential for ulcer 
formation in anuric or 
diverted patient  
1. Reported, major 
problem because 
of potential for 
infection  
1. Reported, major 
problem because of 
potential for infection  
Metabolic consequences of bladder reconstruction with bowel 
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5. Alternatives to gastrointestinal cystoplasty 
Currently, gastrointestinal segments are commonly used as tissues for bladder replacement 
or repair. However, gastrointestinal tissues are designed to absorb specific solutes, whereas 
bladder tissue is designed for the excretion of solutes. As mentioned, when gastrointestinal 
tissue is in contact with the urinary tract, multiple complications may ensue.  
Because of the problems encountered with the use of gastrointestinal segments, numerous 
investigators have attempted alternative methods, materials, and tissues for bladder 
replacement or repair. These include autoaugmentation, ureterocystoplasty, methods for 
tissue expansion, seromuscular grafts, matrices for tissue regeneration and tissue 
engineering with cell transplantation. Some of these alternatives appear to hold promise, but 
none has stood the test of time for true comparison to intestinal cystoplasty.  
An ideal tissue for increasing capacity and improving compliance would have transitional 
epithelium so as to be relatively impermeable and avoid metabolic changes. The lining 
would also prevent mucus production and, probably the increased potential for tumor 
development. The ability to augment the bladder without violation of the peritoneal cavity 
would also decrease morbidity. Two such alternative procedures are ureterocystoplasty and 
autoaugmentation. With ureterocystoplasty, there is good muscle backing of transitional 
epithelium, whereas collagen eventually backs the transitional mucosa of an 
autoaugmentation. 
5.1 Autoaugmentation 
5.1.1 Techniques and results 
Cartwright and Snow (1989) described an ingenious method to improve bladder compliance 
and capacity using native urothelial tissue. In their procedure, known as autoaugmentation 
they excised detrusor muscle over the dome of the bladder leaving the mucosa intact to 
protrude as a wide-mouth diverticulum. Initially they made a midline incision through the 
bladder muscle with the bladder distended with saline so that mucosa bulged from the 
incision. The muscle was mobilized and excised laterally in each direction. The lateral edges 
of the detrusor muscle were then secured to the psoas muscle bilaterally to prevent collapse 
of the diverticulum. Their early experience with a small group of patients resulted in 
improved compliance in most, with increasing capacity in some (78). 
This producer has since been modified by a number of surgeons, particularly in adult 
patients, each providing a different name for the procedure depending on whether the 
detrusor muscle was simply incised (vesicomyotomy) or excised (vesicomyomectomy) to 
create the diverticulum. In an effort to determine whether incision or excision provided 
superior results, Johnson and colleagues (1994) performed 16 vesicomyotomies and 16 
vesicomyomectomies in rabbits after previously reducing the bladder capacity. Functional 
bladder capacity in the animals increased by 43.5%, and there was no statistical difference 
between the two techniques. They then performed vesicomyotomies (incision) in 12 patients 
with neurogenic bladder dysfunction and demonstrated a mean increase in capacity of 40% 
and a mean decrease in leak point pressure of 33% (78, 80). They concluded that detrusor 
excision offered no advantage over incision. All patients demonstrated some increase in 
capacity (15% to 70%), and no patient in early follow-up clinically deteriorated and required 
enterocystoplasty.  
Detrusorectomy, leaving a small cap of muscle at the dome through which a suprapubic 
tube can be placed, was proposed by Landa and Moorhead (1994). They have been 
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concerned that, although these procedures usually improve compliance, the increase in 
volume is "modest" at best (81). 
 
 
In autoaugmentation, the detrusor is excised leaving the urothelium to act as a diverticulum (1). 
The efficacy of autoaugmentation in improving bladder capacity and compliance has been 
varied. Snow and Cartwright (1999) have follow-up of greater than one year in thirty 
patients. Nineteen of thirty patients had a neuropathic bladder secondary to spina bifida. All 
patients had preoperative urodynamic evidence of reduced bladder compliance and 
detrusor hyperreflexia. While clinical success has been dramatic in some, the overall results 
have been less impressive. One third of the patients had a significant increase in bladder 
capacity, an additional third were unchanged, while one third had actual loss of capacity. 
Evaluation of bladder compliance revealed that 60 percent had an improvement in 
compliance by greater than 50 percent in comparison to preoperative measurements, 20 
percent had a 20 to 50 percent improvement, and the remaining did not change significantly. 
Overall fourteen   patients (47%) had excellent results, showing a significant improvement in 
compliance, capacity, and dryness. Seven patients (23%) had fair results, described as 
stability or improvement of the upper tracts without scant improvement in the urodynamic 
parameters. Nine patients (30%) had poor results, remaining wet or with worsening 
hydronephrosis (82). 
Following autoaugmentation, the majority of patients remained on intermittent 
catheterization, although 20 percent demonstrated the ability to void spontaneously. Seven 
patients have required secondary enterocystoplasty following the initial autoaugmentation. 
Reoperative enterocystoplasty was not hampered by the prior detruseroctomy. The 
urothelial diverticulum at the time of augmentation cystoplasty was noted to be thick and 
fibrous similar to a leather bag (82). 
5.1.2 Advantages 
The primary advantage that autoaugmentation has over conventional enterocystoplasty is 
that it preserves the patient's native urothelium in the augmented segment. This avoids the 
complications associated with enterocystoplasty related to the presence of heterotopic 
epithelium in contact with the urine including electrolyte disturbances, mucus, bladder 
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calculi, hematuria dysuria syndrome, and later tumor occurrences. Technically, 
autoaugmentation is an extraperitoneal procedure that can be performed through a 
Pfannestiel incision and avoids the complications of bowel surgery including the 
development of intraperitoneal adhesions and postoperative bowel obstruction. Although 
autoaugmentation is performed without a formal cystotomy; other bladder procedures such 
as ureteral reimplantation and appendicovesicostomy can be performed (intravesically or 
extravesically) at the same time. Lastly, it is important to note that autoaugmentation does 
not preclude further augmentation procedures if unsuccessful.  
5.1.3 Disadvantages 
The major drawback of autoaugmentation is that clinical experience has failed thus far to 
identify the most appropriate patients for this procedure. Mixed results have been obtained 
clinically with regard to symptomatic and postoperative urodynamic improvement in the 
autoaugmented bladder. Evaluations of the available data indicate that there is no direct 
correlation between preoperative urodynamic findings and future success. It works well in 
some patients while it fails in others. It is of note that many patients have demonstrated 
clinical improvement after these procedures without a significant change in urodynamics. 
The exact reasons for the improvement are unknown. 
Another drawbacks of autoaugmentation is a limited increase in bladder capacity. Landa and 
Moorhead (1994) noted that if the maximum capacity and the volume of urine held at 40 cm 
H2O are similar, the patient may be better served by immediate intestinal cysloplasty.. The 
patient and surgeon must be prepared for such an event on occasion. Even if adequate 
expansion is achieved initially, there is concern that any improvement may not last in the long 
term. In animals, the surface area of the autoaugmentation site was observed to decrease by 
approximately 50% at 12 weeks. Progressive thickening and contractor of the site because of 
collagenous infiltrate was noted. Almost one-half of is adult patients with hyperreflexia who 
early on had a good result after autoaugmentation failed with longer follow-up (79).  
An additional concern with autoaugmentation is the theoretical increased risk of bladder 
rupture that has been demonstrated in animal studies. Although perforation of the 
autoaugmented bladder has been reported in one patient, the overall increased risk of bladder 
rupture as compared to other types of bladder augmentation has yet to be defined (83). 
Inadvertent opening of the mucosa during the procedure can make subsequent mobilization 
more difficult and may promote prolonged postoperative extravasation. Such extravasation 
usually stops with bladder drainage. Prolonged drainage, however, may lead to compromised 
results due to collapse of the diverticulum. If concomitant ureteral reimplantation or bladder 
neck surgery is necessary, various authors have recommended that such procedures should be 
done first with the bladder then closed before detrusorectomy.  
5.1.4 Patient selection for autoaugmentation 
Leng and associates (1999), reported good results with the technique among patients with 
hyperreflexia(85). Adequate preoperative volume may be the most important predictor of 
success. Autoaugmentation probably should be considered only in patients who have reasonable 
capacity but poor compliance due to uninhibited contractions(82). If a remarkable increase in 
capacity is needed, autoaugmentation is unlikely to be as definitive as other techniques. 
However, it should be noted that autoaugmentation has been successful in some patients 
with a small capacity, poorly compliant bladder. 
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5.2 Seromuscular grafts and de-epithelialized bowel segments 
5.2.1 Technical considerations 
Seromuscular grafts and de-epithelialized bowel segments, either alone or over a native 
urothelium have been attempted (24, 86). The concept of demucosalizing organs is not new to 
urologists. More than four decades ago, in 1961, Blandy proposed the removal of submucosa 
from intestinal segments used for augmentation cystoplasty to ensure that mucosal 
regrowth would not occur (13).  
Hypothetically, this would avoid the complications associated with use of bowel in 
continuity with the urinary tract. Since Blandy's initial report, 25 years transpired before 
there was a renewed interest in demucosalizing intestinal segments for urinary 
reconstruction (87).   
Several other investigators have pursued this line of research (24, 86, 88). These investigative 
efforts have emphasized the complexity of both the anatomic and cellular interactions 
present when tissues with different functional parameters are combined. The complexity of 
these interactions is emphasized by the observation that the use of demucosalized intestinal 
segments for augmentation cystoplasty is limited by either mucosal regrowth or contraction 
of the intestinal patch (88). 
It has been noted that removal of only the mucosa may lead to mucosal regrowth, whereas 
removal of the mucosa and submucosa may lead to retraction of the intestinal patch (89).  
 
 
Seromuscular enterocystoplasty using sigmoid colon (SCLU). Detrusor incision is 
performed similar to autoaugmentation; however, the bulging mucosa is covered with a 
demucosalized segment of sigmoid colon. (From Buson H, Manivel JC, Dayanc M, et al: 
Seromuscular colocystoplasty lined with urothelium: Experimental study. Urology 
1994;44:745. 
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Seromuscular enterocystoplasty combines autoaugmentation with a demucosalized flap of 
colon or stomach. The removal of the gastrointestinal mucosa results in a denuded 
seromuscular flap that can be placed over the exposed bladder mucosa of an 
autoaugmented bladder to avoid collagen deposition and contraction. This combination has 
been done to potentially preserve the advantages of both procedures. 
5.2.2 Results 
The clinical results of seromuscular enterocystoplasty have been mixed and unpredictable. 
Initial reports by Dewan and Gonzales in both animal models and humans have been 
encouraging (24, 86). In the Gonzales et al series of 16 patients undergoing seromuscular 
colocystoplasty utilizing sigmoid colon, bladder capacity was increased to almost two and 
one half times the preoperative volume and end filling-pressures decreased by 
approximately 50 percent in 14 patients. Two patients failed and required ileocystoplasty 
their urodynamic data were excluded. Two other patients developed an hourglass 
deformity (24). Endoscopic biopsy of the segments was interesting: of 10 biopsies in the 
series, 1 revealed urothelium with islands of colonic mucosa, and 2 others found only colon 
mucosa. Removal of all of the enteric mucosa is important when using sigmoid to prevent 
mucoceles or overgrowth of intestinal mucosa (24).  
Dewan and associates (1997) reported on five patients undergoing seromuscular 
gastrocystoplasty. Four of the five patients have had urodynamic evidence of improved 
bladder capacity and compliance during the first postoperative year. They believed that 
preservation of the submucosa eventually promoted regrowth of bowel mucosa. The 
interaction of the two different tissues will be interesting to follow. The long-term effects on 
the urothelium by the seromuscular segment and vice versa are unknown. Work has shown 
that persistent transitional lining will protect from metabolic problems and mucus 
production (24, 86). 
Despite these initial encouraging results, it is important to note that the follow-up in these 
series has been relatively short and approximately 25 percent of patients have eventually 
required a secondary operation due to either complication related to the seromuscular flap 
(contracture) and/or failure to adequately improve bladder capacity and/or compliance (86). 
A more recent report of long-term follow-up of 13 patients after seromuscular 
gastrocystoplasty by Carr et al (1999) describes variable results, at best. The mean follow-up 
was 50 months. Five patients had a good outcome with regard to objective urodynamic and 
subjective clinical improvement. Four patients were found to have a "fair" outcome in that 
they had some objective improvement, while the remaining four patients had a poor result 
and required re-augmentation (90). Evaluation of preoperative urodynamic and radiographic 
data in these patients again demonstrated that it was not possible to predict preoperatively 
which patients would do well after seromuscular gastrocystoplasty. These procedures are 
technically more demanding than simple augmentation or autoaugmentation and are 
associated with more blood loss and a longer operative time (24). Increased bleeding is 
particularly likely when using stomach.  
These urothelium-lined, seromuscular augmentations are theoretically attractive. Thus far, the 
failure and reoperation rate after such procedures remains higher than that noted for standard 
enterocystoplasty (90). The best results have been reported with the use of colon. Those results 
may be partially attributed to the learning curve with a new, complex procedure. Longer 
follow-up and more experience arc necessary to determine whether the complication rate will 
decrease with experience or increase because of problems with the combination. 
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In summary, seromuscular enterocystoplasty appears to parallel autoaugmentation that is 
technically feasible and useful in many patients. However, it has significant shortcomings. It 
is not possible at this time to define which patients will succeed and which ones will fail. 
Advantages beyond autoaugmentation appear to be minimal. Further long-term studies are 
required to determine the true efficacy of this technique. Also, additional studies are needed 
to determine if there are significant functional differences between seromuscular 
colocystoplasty and seromuscular gastrocystoplasty. 
5.3 Ureterocystoplasty 
The use of ureteral tissue for bladder augmentation purposes was first described in 1992 (91). 
Native ureter is for many reasons the best tissue available for augmentation cystoplasty. It is 
autologous, lined with urothelium, backed by muscle, distensible, and complaint (92, 93). 
However, not all patients in need of bladder augmentation have dilated ureteral tissue 
available for use. Patients that are candidates for ureterocystoplasty should have either i) a 
nonfunctional renal unit that can be removed making the ureter and renal pelvis available, 
or ii) a functional renal unit that is associated with a massively dilated, tortuous, and 
elongated ureter. The lower ureter can then be used for augmentation, while kidney 
drainage is re-established by reimplantation of the straightened upper ureter into the 
bladder or by transureteroureterostomy.  
An example of an ideal candidate is one with vesicoureteral reflux and dysplasia (VURD) 
syndrome from posterior urethral valves. In patients with posterior urethral valves, 
unilateral reflux may behave as a "pop-off" valve to lower intravesical pressures and protect 
the contralateral upper tract. In many of these patients, the refluxing ureter is massively 
dilated, draining a poorly functioning or nonfunctioning kidney. It was a logical extension 
to use this ureteral tissue to augment the bladder. Ureterocystoplasty is also appropriate in 
patients on dialysis with end-stage renal failure who are awaiting transplantation and are in 
need of augmentation due to bladder dysfunction.  
More recently, the use of ureterocystoplasty has been expanded in an attempt to take 
advantage of this valuable tissue and make it available to more surgical candidates. Its use 
has been reported in patients with a duplex system in which either the upper or lower pole 
is nonfunctioning (96). In patients with a duplex system and a dilated ureter in conjunction 
with a functioning renal segment, drainage of that segment can be accomplished with an 
ipsilateral ureteroureterostomy with preservation of the lower portion of the ureter for 
augmentation. Ahmed et al have also described the "tandem" use of bilateral megaureters 
for ureterocystoplasty (97). 
5.4 Technical considerations 
Ureterocystoplasty can be performed through a midline, intraperitoneal incision. This 
incision provides access to the intestine should mobilization of the ureter be unsatisfactory. 
Ureterocystoplasty may also be done through two incisions, remaining completely 
extraperitoneal. The general technique is the same. A standard nephrectomy is performed 
with great care to preserve the renal pelvic and upper ureteral blood supply. All adventitia 
and periureteral tissue is swept from the peritoneum toward the ureter during mobilization 
to protect the ureteral blood supply. Proximally, this blood supply typically arises medially. 
As the ureter enters the true pelvis, the blood supply arises posteriorly and laterally.  
After mobilization of the ureter into the pelvis, the bladder is opened in the sagittal plane. 
Posteriorly, this incision has typically been carried offcenter directly into and through the 
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ureteral orifice of the ureter used for cystoplasty. The ureter is not detached from the 
bladder but is opened longitudinally along its entire length, with care taken to avoid its 
main blood supply. The incision in the bladder and distal ureter should avoid branches of 
the superior vesical artery, which serves as an important blood supply to the mobilized 
ureter. The ureter is folded on itself, and the ureter-to-ureter and ureter-to-bladder 
anastomoses are performed with running absorbable suture.   
Alternatively, the bladder incision can be stopped approximately 2 cm from the orifice, with 
a similar length of distal ureter left in situ and intact without incision. The resulting small 
loop of intact ureter does not create clinical problems or adversely affect the end volume in a 
significant manner (20). This modification of technique is easier and may be safer in that, it 
avoids potential injury to the blood supply of the mobilized ureter near the ureterovesical 
junction. 
 
 
A) A megaureter and poorly functioning kidney are required for ureterocystoplasty.                    
B) After nephrectomy, the dilated ureter is detubularized, taking care to preserve the blood 
supply.  C) The detubularized ureter is reconfigured before being anastomosed to the 
bladder (1). 
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5.4.1 Results         
Numerous series have reported good results after augmentation using ureter, some with 
follow-up as long as 8 years. The upper tracts have remained stable or improved in virtually 
all patients. Complications have been uncommon, with only a rare early extravasation of 
urine reported (92). 
The largest published series is that of Churchill et al (1993) in which ureterocystoplasty was 
performed in 16 patients. Thirteen patients had enough urodynamic data available 
postoperatively for adequate evaluation. Twelve out of thirteen patients had excellent results. 
As a group, there was a 218 percent increase in bladder capacity, a 284 percent increase in 
pressure specific bladder capacity, and a 227 percent increase in bladder compliance. 
Landau and colleagues (1994), compared age-matched and diagnosis-matched children who 
underwent ureterocystoplasty or ileocystoplasty. The total mean bladder capacity was 470 
ml in the ureterocystoplasty group and 381 ml in the ileocystoplasty group. Bladder 
volumes at 30 cm H2O were 413 ml and 380 ml after ureterocystoplasty and ileocystoplasty, 
respectively. Ureter effectively enhanced both volume and compliance. They reported no 
significant differences in the postoperative mean increase in bladder capacity and pressure 
specific bladder volume. Both procedures resulted in excellent functional results (94).  
Hitchcock et al (1994) has described similar excellent short-term results in eight patients (95). 
5.4.2 Advantages 
There are several advantages of using the ureter for augmentation. As is the case with 
autoaugmentation, the major advantage of ureterocystoplasty is that the native urothelium 
is preserved, thereby avoiding the specific potential problems associated with the use of 
bowel. Unlike some cases following autoaugmention, the full thickness opened ureter does 
not tend to shrink with time, unless the vascular supply is compromised. In patients with 
end-stage renal disease, the procedure can be performed extraperitoneally, thus, preserving 
the peritoneum for future peritoneal dialysis. When necessary, concomitant procedures in 
the bladder may also be performed. It seems likely that the risk of tumor formation will be 
avoided, and perforation of the augmented bladder may be less probable. However, long-
term follow-up will be needed to confirm these notions (92). Lastly, there is increased 
potential for spontaneous voiding postoperatively in patients who are able to empty their 
bladders adequately preoperatively. 
5.4.3 Disadvantages 
The main disadvantage of ureterocystoplasty is that it is only applicable in a minority of 
patients. Surgical candidates for ureterocystoplasty include patients with either a 
nonfunctioning renal unit or a megaureter long enough that ipsilateral renal drainage can be 
re-established following use of the lower ureter for augmentation (92).  
6. To the future: Tissue expansion for bladder augmentation 
6.1 The experiments 
In an attempt to make ureterocystoplasty available to make to patients with non-dilated 
ureters, some have developed methods of producing a dilated ureter. Lailas et al (1996) have 
demonstrated in a rabbit model that a temporary cutaneous ureterostomy can be used to 
perform hydrostatic distention of the ureter with subsequent successful ureterocystoplasty. 
In this study, the ureteral units were dilated at least 10 fold, as measured by radiography, 
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after daily injection of a saline-antibiotic solution for 1 month. Augmentation cystoplasty 
was performed with the reconfigured dilated uretral segment. Repeated cystography and 
cystometry showed an increased bladder capacity ranging from 190 % to 380% (98). In a 
similar system, a dilating catheter was used to dilate tissue in pigs (99).   
 
 
Progressive dilation can be performed in a normal-caliber ureter, which can be subsequently 
used for ureterocystoplasty. After placement of a ureteral dilation device, comparison is 
made of progressively dilated ureter (du) and native undilated ureter (u) coming off the 
bladder (b) (13). 
A system for the progressive expansion of native bladder tissue has also been used for 
augmenting bladder volumes (Satar et al, 1999). Beagle dogs underwent urodynamic studies 
and the bladders were divided horizontally into two segments: a superior bladder 
neoreservoir, and an intact smaller bladder inferiorly with both ureters left intact and 
draining. A silastic catheter was threaded into the newly formed, superiorly located 
neoreservoir, and connected to an injection port, which was secured subcutaneously. Four 
weeks after surgery, a saline-antibiotic solution was injected daily into the palpable injection 
port. Dilating the neoreservoir through the silastic catheter within 30 days after progressive 
dilation, the neoreservoir volume was expanded at least 10-fold, as measured by 
radiography and cystometrography. Urodynamic studies of the dilated neoreservoirs 
showed normal compliance in all animals. Microscopic examination of the expanded 
neoreservoir tissue showed a normal histology (100).  
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Progressive bladder dilation can be performed with adequate increases in capacity. 
Cystography of bladder neoreservoir before progressive dilation (A) is compared with 
cystography results after progressive dilation (B) and with cystogram showing dilated 
neoreservoir and intact bladder segment (C) (13) 
6.2 The expectations 
Ideally, bladder tissue expansion could be performed with an indwelling dilation catheter, 
similar to a Foley catheter with a large balloon. In the future, one could foresee placing a 
dilating catheter intravesically in a patient who either requires augmentation, in an 
intermittent fashion (e.g. four times daily) or left indwelling. An expanding balloon within 
the catheter could then be filled progressively, with either continuous or intermittent filling 
until the desired bladder volume is achieved. Studies associated with this concept are 
currently being conducted in the laboratory. Clinical application of these interesting ideas 
has yet to be undertaken (13). 
7. Tissue engineered bladder 
The complications that are associated with using various portions of the gastrointestinal 
tract for genitourinary reconstruction in both adults and children have stimulated the 
development of tissue engineering techniques for bladder reconstruction through bladder 
regeneration. Current research efforts are focused on the development of biodegradable 
materials which are well-characterized with predictable behavior that can be used as 
alternatives to gastrointestinal segments for bladder reconstruction. 
Tissue engineering follows the principles of cell transplantation, materials science, and 
engineering toward the development of biologic substitutes that can restore and maintain 
normal function. Bladder reconstruction via tissue engineering and bladder regeneration 
involve the use of a biomaterial graft (matrix), either permanent or biodegradable, that will 
function as a suitable scaffold to allow the body’s ability of regeneration and growth to 
occur either naturally (matrices alone unseeded) or with the addition  of cultured cells 
(matrices with cell – seeded) (3, 101). 
The ideal graft material is one that would be replaced by the host tissue, provide a low-
pressure reservoir, and serve as a scaffold for regeneration of the bladder wall with normal 
function characteristics. If a suitable graft material can be developed, the need for 
autogenous tissue and the associated complications of intestinal segments could be 
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eliminated. Currently, there are two types of tissue engineering technologies that have 
preliminarily been shown to induce bladder regeneration. These are the unseeded and 
seeded technologies (14).   
7.1 Biomaterials 
7.1.1 Functions  
Biomaterials in genitourinary tissue engineering function as an artificial extracellular matrix 
(ECM) and elicit biologic and mechanical functions of native ECM found in tissues in the 
body. Native ECM brings cells together into tissue, controls the tissue structure, and 
regulates the cell phenotype. Biomaterials facilitate the localization and delivery of cells 
and/or bioactive factors (e.g. cell adhesion peptides, growth factors) to desired sites in the 
body; define a three dimensional space for the formation of new tissues with appropriate 
function. The configuration of the biomaterials can guide the structure of an engineered 
tissue. The biomaterials provide mechanical support against in-vivo forces of tissue 
development. The biomaterials can be loaded with bioactive signals, such as cell-adhesion 
peptides and growth factors, which can regulate cellular function (102).  
7.1.2 Design and selection 
The design and selection of the biomaterial is critical in the development of engineered 
genitourinary tissues. The biomaterial must be capable of controlling the structure and 
function of the engineered tissue in a predesigned manner by interacting with transplanted 
cells and/or host cells. Generally, the ideal biomaterial should be biocompatible, promote 
cellular interaction and tissue development, and possess proper mechanical and physical 
properties. 
The selected biomaterial should be biodegradable and bioresorbable to support the 
reconstruction of a completely normal tissue without inflammation. Such behavior of the 
biomaterials avoids the risk of inflammatory or foreign body responses that may be 
associated with the permanent presence of a foreign material in the body. The degradation 
products should not provoke inflammation or toxicity, and must be removed from the body 
via metabolic pathways. The degradation rate and the concentration of degradation 
products in the tissue surrounding the implant must be at a tolerable level (103).  
The biomaterials need to be processed into specific configuration. A large ratio of surface 
area to volume is often desirable to allow the delivery of a high density of cells. A high-
porosity, interconnected pore structure, with specific pore sizes promotes tissue ingrowth 
from the surrounding host tissue. Several techniques have been developed that readily 
control porosity, pore size, and pore structure (13). 
7.1.3 Types of biomaterials 
Generally, three classes  of biomaterials have been used for engineering of genitourinary 
tissue: synthetic polymers, such as polyglycolic acid (PGA), polylactic acid (PLA),  and poly-
lactic-co-glycolic acid) (PLGA), naturally derived materials, such as collagen and alginate; 
and cellular tissue matrices, such as bladder submucosa and small-intestinal submucosa. 
These classes of biomaterials have been tested in regard to their biocompatibility with 
primary human urothelial and bladder muscle cells. Naturally, derived materials and 
cellular tissue matrices have the potential advantage of biologic recognition. Synthetic 
polymers can be produced reproducibly on a large scale with controlled properties of 
strength, degradation rate, and microstructure (105). 
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7.2 Matrices for bladder regeneration 
A. Unseeded matrices (Acellular)  
The first technique currently being investigated for bladder regeneration is the unseeded 
technology. This technology involves placement of matrix graft into the wall of the host-
bladder. The body then provides the needed environment for subsequent cell growth and 
tissue regeneration. This represents an unseeded bladder regenerating process.  
Thus far, the major obstacle to unseeded tissue engineering technology has been the 
inability to develop an optimal biomaterial that will act as a suitable scaffold for the 
"natural" process of regeneration. 
7.2.1 Synthetic non-biodegradable biomaterials 
Synthetic non-biodegradable biomaterials such as silicon, Teflon, rubber, 
polytetrafluoroethylene, and polypropylene have been tried with unsuccessful results 
because of host foreign body reactions. Most of these attempts have failed because of 
mechanical, structural, functional, or biocompatibility problems. Usually, permanent 
synthetic materials used for bladder reconstruction succumb to mechanical failure and 
urinary stone formation, and use of degradable materials leads to fibroblast deposition, 
scarring, graft contracture, and a reduced reservoir volume over time.  
7.2.2 Synthetic biodegradable biomaterials 
 As a consequence of these failures with non biodegradable materials, synthetic 
biodegradable material e.g. collagen and Vicryl (PGA) matrices were developed in the hope 
that these grafts would allow the host bladder adequate time for regeneration but dissolve 
prior to sever foreign body reaction. These materials have been used experimentally and 
have shown less graft encrustation and infectious complications compared to non-
biodegradable materials. However, graft shrinkage still limited potential clinical utility of 
these materials. 
Collagen/Vicryl composite membranes were used as a scaffold for tissue ingrowth to repair 
a full thickness defect in the bladder of rabbits. The collagen membranes were reinforced 
with meshes of Vicryl, a biodegradable polimer composed of PLGA, to strengthen the 
collagen membranes, which are too soft to suture reliably. The results of the initial study 
were not encouraging because of the occurrence of sever infection (Monsour et al, 1987). 
However, a later study obtained a high success rate when the experiments were repeated 
using purification and γ irradiation of collagen and postoperative administration of 
antibiotics. At 3 weeks, a normal urothelium was noted. At 6 weeks, no implanted 
biomaterial was identified. At 35 weeks, smooth muscle regeneration was evident. During 
this period, there was no evidence of urinary leakage, infection, or bladder calculi (Scott et 
al, 1988). 
7.2.3 Natural biodegradable materials 
Collagen based matrices for tissue regeneration such as placenta, amnion and pericardium 
have been investigated in dogs and have shown clear evidence of bladder regeneration (106, 
107, 108). Functionally, the implanted bladders showed adequate capacity for up to 36 months. 
Nevertheless, they were observed grossly to undergo graft shrinkage. Histologically, the 
epithelial layer was present, but the muscular layer was absent. 
However, despite initial encouraging results, none of these materials has been found to be 
suitable for clinical use. The reasons for this are not entirely clear. It can only be speculated 
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from the available literature that long-term experimental results with these biodegradable 
materials did not recapitulate the initial results and therefore clinical trials were not 
undertaken.  
7.2.4 Acellular Extracellular Matrix (ECM) grafts 
Recently there has been the development of new types of biodegradable materials that have 
shown tremendous potential for the induction of bladder regeneration with unseeded tissue 
engineering technology. These materials are acellular extracellular matrix (ECM) grafts that 
are derived from various different organs. The graft is made acellular by a mechanical 
process that lyses the cells and/or by detergent and enzymatic extraction. These types of 
ECM grafts may be xenogenic or allogenic and have been derived from full thickness 
bladder, stomach, and the submucosal layer of small intestine (109). 
7.2.5 Xeogenic acellular matrix grafts  
Small Intestinal Submucosa (SIS) 
The most thoroughly studied collagen based ECM graft for bladder augmentation and 
urinary reconstruction utilizing unseeded technology is small intestinal submucosa (SIS) 
(109). SIS is a xenogentic membrane derived from pig small intestine in which the mucosa is 
mechanically removed from the inner surface and the serosa and muscularies are 
mechanically removed from the outer surface. This result in a thin, translucent membrane 
(0.1 mm wall thickness) composed mainly of the submucosal layer of the intestinal wall. 
Production of SIS is reminiscent of the manufacturing of sausage casing. This unique 
material has been shown to function well as an arterial or venous graft with rapid 
replacement by native tissues and evidence of tissue specific regeneration (101). 
SIS grafts have been shown to promote full thickness bladder regeneration in both rat and 
canine animal models. The regenerated bladder tissue is composed of all three layers of the 
normal bladder wall (urothelium, smooth muscle, and serosa). In addition, the regenerated 
segment is contractile, compliant, and functionally innervated. Urodynamic studies in a 
long-term canine augmentation model have demonstrated that the SIS augmented bladder 
maintains normal bladder capacity and compliance that persist for at least 15 months 
postoperatively. In vitro muscle strip studies on the regenerated portions of the bladders 
also demonstrate contractility and compliance that is similar to normal bladder (110). 
SIS has been shown to be non-immunogenic with over 1000 cross species transplants and 
direct challenge testing elucidating no response. In addition, SIS is unique from other 
biomaterials that have been studied thus far in that it contains a combination of active 
intrinsic growth factors, cytokines, structural proteins, glyeoproteins, and proteoglycans 
that may assist in cell migration, cell-to-cell interaction, as well as cell growth and 
differentiation during the regenerative process. These inherent elements within SIS may 
prove to be vital to the regenerative process. Further research is needed to identify the 
functional importance of each of these elements and factors (101). 
7.2.6 Allogenic acellular matrix grafts  
Bladder Acellular Matrix Grafts (BAMG) 
Similar types of cellular ECM grafts to SIS have also been shown to induce bladder 
regeneration in vivo. Preliminary works have demonstrated that successful morphologic 
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and functional regeneration of the rat urinary bladder can be accomplished with 
homologous bladder acellular matrix grafts (BAMG). 
The allogeneic acellular bladder matrix has served as a scaffold for the ingrowth of host 
bladder wall components in rats. The matrix was prepared by mechanically and chemically 
removing all cellular components from bladder tissue. Partial cystectomy (25% to 50%) was 
performed, followed by augmentation cystoplasty using acellular bladder matrices. The 
mucosal lining was complete within 10 days. After 4 weeks, muscular and vascular 
regeneration was completed. Nerve regeneration continued to improve until week 20. The 
grafted bladders had significantly better capacity and compliance than the autoregenterated 
bladders after partial cystectomy alone. The bladders regenerated with acellular matrix 
grafts exhibited contractile activity to electric and carbachol stimulation. Clinically relevant 
antigenicity was not evident. However, there was a 26% to 36% incidence of bladder stone 
formation (111, 112). 
B. Seeded matrices 
Allogenic Cellular Matrix Grafts 
In multiple studies using various materials as acellular grafts for cystoplasty, the urothelial 
layer was able to regenerate normally, but the muscle layer, although present, was not fully 
developed (111, 112, 113).  
Allogenic bladder submucosa preloaded with cells was used as a biomaterial for bladder 
augmentation in dogs (113). The regenerated bladder tissues contained a normal cellular 
organization consisting of urothelium and smooth muscle and exhibited a normal 
compliance. Biomaterials preloaded with cells before their implantation showed better 
tissue regeneration compared with biomaterials implanted with no cells, in which tissue 
regeneration depended on ingrowth of the surrounding tissue. The bladders showed a 
significant increase (100%) in capacity when augmented with scaffolds seeded with cells, 
compared to scaffolds without cells (30%). 
7.2.7 Summary 
Studies involving acellular matrices that may provide the necessary environment to 
promote cell migration, growth, and differentiation are being conducted, and demonstrate 
that bladder regeneration using unseeded tissue engineering technology is feasible without 
the complications of graft shrinkage, incrustation, and infection. These observations have 
obvious and significant clinical ramifications. The ability to augment the bladder without 
the use of bowel or other native host tissue would eliminate many of the complications of 
conventional enterocystoplasty and would simplify the technical aspects of this operation. 
Further research into the individual composition of the various biomaterials, the cell-to-cell 
interaction, and the growth factors that are involved in the bladder regenerative process will 
be required prior to clinical use of these grafts.  
7.3 Bladder tissue engineering with selective cell transplantation (seeded technology) 
The second type of tissue engineering technology, the seeded technique, involves the use of 
biodegradable materials that act as cell delivery vehicles for cultured cells from the patient. This 
technique has been applied to the urinary bladder. Initially, this process is begun by 
harvesting native bladder tissue for the establishment and expansion of primary cultures of 
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Scanning electron micrographs of biomaterials: collagen sponge (top), acellular matrix 
prepared from pig bladder submucosa (center), and polyglycolic acid fiber-based matrix 
(bottom). (Size bars = 100 μm.) (13). 
both bladder smooth muscle and epithelial sells. It is possible to expand a bladder epithelial 
cell culture from a single biopsy specimen such that the cultured cells could cover a surface 
area of over 400 m within eight weeks (14). Once the cells are grown, they are seeded on a 
biodegradable membrane in vitro and then transplanted back into the host for continuation 
of the regenerative process.  
In 1992, 1993 Atala and associates demonstrated the successful use of non-woven 
polyglycolic acid polymers sheets, which allow the in-vitro growth of rabbit and human 
bladder epithelium and smooth muscle cells (114, 115). Further work demonstrated that these 
cell-polymer constructs could be implanted into athymic mice with the subequent formation 
of organized layers of bladder epithelial and smooth muscle cells.  
In these studies, urothelial and muscle cells were expanded in-vitro, seeded onto a polymer 
scaffold (non-wonen polygycolic acid), and allowed to attach and form sheet of cells. The 
cell-polymer scaffold was then implanted in-vivo. A series of in vivo urologic associated 
cell-polymer experiments were then performed. Histologic analysis of human urothelial, 
bladder muscle, and composite urothelial and bladder muscle polymer scaffold, implanted 
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in athymic mice and retrieved at different time points, indicated that viable cells were 
evident in all three experimental groups (115). Implanted cells oriented themselves spatially 
along the polymer surfaces. The cell populations appeared to expand from one layer to 
several layers of thickness with progressive cell organization over extended implantation 
times. Cell-polymer composite implants of urothelial and muscle cells, retrieved at extended 
times (50 days), showed extensive formation of multilayered, sheet-like structures and well 
defined muscle layers. Polymers seeded with cells and manipulated into a tubular 
configuration showed layers of muscle cells lining the multilayered epithelial sheets. Cell 
polymers implanted with human bladder muscle cells alone showed almost complete 
replacement of the polymer with sheets of smooth muscle at 520 days. This experiment 
demonstrated that composite tissue-engineered structures could be created de novo.  
Recently, Yoo et al (1998) and Oberpenning et al (1999), reported on the feasibility of dog 
bladder augmentation using allogenic bladder submucosa or polyglycolic acid polymers 
seeded with urothelial and smooth muscle cells (113, 116). Organized bladder histology was 
noted in the regenerated bladder tissue. More importantly, the regenerated bladder tissue 
was found to increase bladder capacity and was urodynamically compliant. 
In order to determine the effect of implanting engineered tissues in continuity with the 
urinary tract, Yoo and associates (1998), used an animal model of bladder augmentation. 
Partial cystectomies, which involved removal of approximately 50% of the native bladder, 
were performed in 10 dogs. In five, the retrieved bladder tissue was micro dissected and the 
mucosal and muscular layers separated. The bladder urothelial and muscle cells were 
cultured. Urothelial and smooth muscle cells were harvested and expanded separately. A 
collagen-based matrix, derived from allogenic bladder submucosa, was used for cell 
delivery. This material was chosen for these experiments because of its native elasticity.  
 
 
Radiographic cystograms in beagles 11 months after subtotal cystectomy without 
reconstruction (A); with reconstruction using a polymer without cells (B); and with 
reconstruction with a polymer and cell-seeded tissue-engineered organ (C). Organs after 
trigone-sparing cystectomy retained a small-sized reservoir. Tissue-engineered neobladders 
showed a normal configuration and a larger capacity than the trigones grafted with polymer 
only (13). 
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Within 6 weeks, the expanded urothelial cells were collected as a pellet. The cells were 
seeded on the luminal surface of the allogenic bladder submucosa and incubated for five 
days. Muscle cells were seeded on the opposite side of the bladder submucosa. 
Augmentation cystoplasty was performed with the matrix including cells in one group and 
the matrix without cells in the second group. The augmented bladders were covered with 
omentum to facilitate angiogenesis to the implant. Bladders augmented with the matrix 
seeded with cells showed a 99% increase in capacity compared with bladders augmented 
with the cell-free matrix, which showed only a 30% increase in capacity. Functionally, all 
animals showed normal bladder compliance as evidenced by urodynamic studies; however, 
the remaining native bladder tissue may have accounted for these results. Histologically, the 
retrieved engineered bladders contained a cellular organization consisting of a urothelium-
lined lumen surrounded by submucosal tissue and smooth muscle. However, the muscular 
layer was markedly more prominent in the cell-reconstituted scaffold (113). 
7.3.1 Histologic Parameters of Tissue-Engeneered Bladders 
It has been well established for decades that the bladder is able to regenerate generously 
over free grafts. Urothelium is associated with a high reparative capacity. Bladder muscle 
tissue is less likely to regenerate in a normal fashion. Most of the free grafts (without cells) 
used for bladder replacement in the past were able to show adequate histology in terms of a 
well-developed urothelial layer, but they were associated with an abnormal muscular layer 
that varied in terms of its full development. Because native muscle cells are less likely to 
regenerate over the free grafts, presence of both urothelial and muscle cells on the matrices 
used for bladder replacement is important for successful tissue bioengineering. 
Both urothelial and muscle ingrowth are believed to be initiated from the edges of the 
normal bladder toward the region of the free graft. Usually, however, contracture or 
resorption of the graft has been evident. The inflammatory response toward the matrix may 
contribute to the resorption of the free graft (89,104).  
It was hypothesized that building the three-dimensional structure constructs in vitro, before 
implantation, would facilitate the eventual terminal differentiation of the cells after 
implantation in vivo and would minimize the inflammatory response toward the matrix, 
thus, avoiding graft contractor and shrinkage.  The study by Yoo and associates (1998) 
demonstrated a major difference between matrices used with autologous cells (tissue-
engineered matrices) and those used without cells as regards the graft diameter (113). 
Matrices implanted with cells for bladder augmentation retained most of their implanted 
diameter, as opposed to matrices implanted without cells for bladder augmentation, in 
which graft contraction and shrinkage occurs.  
7.3.2 Functional parameters of tissue-engeneered bladders 
The results of initial studies showed that the creation of artificial bladder may be achieved in 
vivo; however, it could not be determined whether the functional parameters noted were 
caused by the augmented segment or by the intact native bladder tissue. To better, address 
the functional parameters of tissue-engineered bladders; an animal model was designed that 
required a cystectomy with subsequent replacement organ (116). 
A total of 14 dogs underwent a trigone-sparing cystectomy. The animals were randomly 
assigned to one of three groups.  Group A (n= 2) underwent closure of the trigone without a 
reconstructive procedure. Group B (n= 6) underwent reconstruction with a cell- free bladder 
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shaped biodegradable polymer. Group C (n=6) underwent reconstruction using a bladder-
shaped biodegradation polymer that delivered autologous urothelial cells and smooth 
muscle cells harvested from autologous bladder biopsy and expanded. 
The cystectomy -only controls and polymer-only grafts maintained average capacities of 
22% and 46% of preoperative values, respectively. An average bladder capacity of 95% of 
the original precystectomy volume was achieved in the tissue-engineered bladder 
replacements. 
The subtotal cystectomy reservoirs that were not reconstructed and the polymer-only 
reconstructed bladder showed a marked decrease in bladder compliance (10% and 42% total 
compliance). The compliance of tissue-engineered bladders showed almost no difference 
from preoperative values.  Histologically, the polymer-only bladder presented a pattern of 
normal urothelial cells with a thickened fibrotic submucosa and a thin layer of muscle fibers. 
The retrieved tissue- engineered bladders showed a normal cellular organization, consisting 
of a trilayer of urothelium, submucosa, and muscle. The results from this study showed that 
it is possible to tissue - engineer bladders that are anatomically and functionally normal (116).  
Clinical trials for the application of this technology are currently being arranged (116). 
Progressive bladder dilation can be performed with adequate increases in capacity. 
Cystography of bladder neoreservoir before progressive dilation (A) is compared with 
cystography results after progressive dilation (B) and with cystogram showing dilated 
neoreservoir and intact bladder segment (C) 
7.3.3 In summary  
It is clear that bladder regeneration is possible utilizing both unseeded and seeded tissue-
engineering technologies.  Further advances in our current techniques will eventually 
revolutionize urologic reconstructive surgery, as we know it today. It is important to note 
that all of the animal studies performed thus far have been in animals with a normal 
bladder. It is not known whether normal or abnormal bladder regeneration can be achieved 
with either unseeded or seeded technology in an animal or patient with a neuropathic 
bladder. Active research is currently investigating this vital question. Additionally, studies 
are needed to better understand the differences that exist between the unseeded and seeded 
approaches and the resultant regenerated bladder, so that unseeded and aspect approaches 
and the resultant regenerated bladder so that the best aspects of each technology may be 
utilized to achieve a superior result. It is the authors' opinion that future chapters on bladder 
augmentation will discuss the use of intestinal segments as historical footnote while the 
major focus will be on the indications and methods for various types of tissue engineering 
technology. 
8. Laparoscopic augmentation cystoplasty 
8.1 Laparoscopic  enterocystoplasty 
8.1.1 Patient selection 
Laparoscopy has distinct advantages when compared with open surgical procedures, such 
as decreased postoperative pain and morbidity, improved cosmoses, a shorter hospital stay, 
and decreased convalescence. Recent studies have indicated that postoperative intra-
abdominal adhesions are reduced significantly after laparoscopic surgery when compared 
with open surgery (117). 
www.intechopen.com
 Understanding the Complexities of Kidney Transplantation 
 
322 
 
Alternative  Advantages  Disadvantages  
Ureter  1. Urinary epithelium, no 
mucus  
2. Good compliance  
1. Only applicable if the 
patient has a dilated 
ureter  
2. Ureter may be scarred 
(reflux, infection)  
Autoaugmentation  
(bladder myomectomy)  
1. Urinary epithelium, no 
mucus  
2. Relatively easy, no 
bowel resection  
1. Inconsistent results can 
result in bladder scarring  
2. Sometimes difficult 
(bladder scarring or 
diverticula)  
Demucosalized intestinal 
flap  
on urothelium (colon, 
DAWG)  
1. Urinary epithelium, 
decreased mucus  
2. More physiologic  
1. Difficult procedure  
2. Inconsistent results  
Bladder regeneration on  
substrate (SIS)  
1. No bowel resection  
2. Easily performed  
1. Unproven in children  
2. Dependent on native 
bladder potential for 
regeneration  
Tissue engineering  1. Bladder regrowth in 
laboratory  
2. Potentially unlimited 
capacity, no mucus  
1. Unproven in children  
2. Dependent on vascular 
and nerve ingrowth  
DAWG, demucosalized augmentation with gastric segment.  
Alternatives to intestinocystoplasty  
Despite the established role of laparoscopy in diagnostic and ablative urologic surgery, the 
use of laparoscopic techniques in reconstruction has been limited because of the technical 
complexity of the procedures involved. The technical steps in performing laparoscopic 
bladder augmentation are designed to emulate the open surgical counterpart in every 
aspect, thereby producing similar functional results with an improved recovery. 
A relative contraindication specific to laparoscopic bladder augmentation is the presence of 
extensive intra-abdominal and pelvic adhesions that would preclude laparoscopic 
dissection. Patients with ventriculo-peritoneal shunts, as noted in cases of 
myelomeningocele, have increased abdominal adhesions that may preclude a successful 
laparoscopic approach (117). 
8.1.2 Technical considerations  
Important elements of the operation include:  
 Cystoscopic placement of ureteric catheters (optional).  
 Transperitoneal placement of 4 to 5 redially arranged trocars.  
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 Identification of the cecum and ileocecal junction.  
 A 5-mm laparoscope can be introduced through the lower left port to transilluminate 
the mesentery and identify its vascular pedicle. 
 Bowel segment selection and mobilization sufficient for pelvic placement.  
 Exteriorizing the bowel loop outside the abdomen through a 2-cm extension of the 
umbilical port site, preventing twisting of the mesenteric vessels;  
 Using traditional open surgical techniques, the bowel segment is isolated, bowel 
continuity is re-established, mesenteric window is closed, the bowel segment is 
detubularized along its antimesenteric border and reconfigured (117,118). 
 Alternatively, bowel division and side-to-side anastomosis may be done 
intracorporeally using endoscopic gastrointestinal stapling device with 
detubularization and freehand intracorporeal suturing to reconfigure the bowel (119). 
 Incising the peritoneum, entering the space of Retzius, mobilization of the bladder.  
 Vertical incision creating a large cystotomy (bivalving).  
 Mobilization of the bowel patch, and fixing it at 6 and 12-o’clock positions.  
 Circumferential completion of enterovesical anastomsis in quadrants intracorporeally 
with running sutures.  
8.1.3 Results 
Hedican and associates (1999) performed laparoscopic assisted bladder augmentation in 
eight patients. In addition to using a bowel segment for augmentation, in many of these 
cases they were also able to laparoscopically mobilize the appendix to perform a Mitrofanoff 
continent catheterizable stoma. They described using both ileum and cecum as the enteric 
patch for the bladder. The bladder augmentation was done through a low Pfannenstiel 
incision. Many of these patients were children and this allowed a rapid recovery with 
decreased pain as well as a good cosmetic result (120).  
Gill and associates (2000) underwent laparoscopic enterocystoplasty for three patients with 
functionally reduced bladder capacities due to neurogenic causes: ileocystoplasty (n=1), 
sigmoidocystoplasty (n=1), and cystoplasty with cecum and proximal ascending colon 
(n=1). In all patients, bowel reanastomosis was performed by exteriorizing the bowel loop 
outside the abdomen. All three laparoscopic enterovesical anastomoses were water tight 
without postoperative urinary extravasation. The operative times were 5.3, 8, and 7 hours. 
The hospital stay was 7, 5, and 4 days (118). 
Rackley and associates (2001) performed laparoscopic enterocystoplasty in 12 patients with 
functionally reduced bladder capacities owing to neurogenic causes. Procedures included 
ileocystoplasty (2), sigmoidocystoplasty (2), colocystoplasty (1), and cecocolocystoplasty 
with continent catheterizable ileal stoma (7). Total surgical time ranged from 5.3 to 8 hours 
(average 7.0 hours). The time of laparoscopic suturing ranged from 1.7 to 3.1 hours (average 
2.4 hours). Blood loss was minimal and did not exceed 250 ml during any of the procedures 
(average 175 ml). The only intra-operative complication was a trocar-induced rectus sheath 
hematoma. Oral feeding was resumed by 24 hours in 11 of the 12 patients. The average 
hospital stay was 5.7 days and ranged from 3 to 7 days (117). 
Unlike the previously published reports, where portions of the procedure were performed 
extracorporeally, Elliott and associates (2002) reported their technique of complete 
laparoscopic ileocystoplasty (119). 
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8.2 Laparoscopic autoaugmentation  
Ehrlich and Gershman (1993), reported the first laparoscopic autoaugmentation in an 8-
years-old child with a neurogenic bladder. In this case, the procedure required 70 min, 
follow-up of the patient at 1 year, documented improvement in his symptoms with rare 
incontinence (121). 
In 1995, McDougall and colleagues described the initial laparoscopic retropubic 
autoaugmentation of the bladder in an adult (12). In this case, the extraperitoneal approach 
was used and the incision was made in the detrusor muscle leaving the mucosa intact. There 
was a significant drop in bladder pressure. At the 6-month follow-up, the bladder capacity 
increased from 85-350 ml. However, in a second case, while the procedure could be 
successfully completed, the long-term result was unsatisfactory.  
Due to the success of enteric augmentation and the variable results with autoaugmentation, 
this procedure has largely fallen into disuse (122). Nevertheless, laparoscopic retropubic 
autoaugmentation allows a brief hospital stay and minor postoperative discomfort. 
Moreover, the laparoscopic approach should not complicate or preclude subsequent 
enterocystoplasty if necessary (123). 
9. Conclusion 
Laparoscopic enterocystoplasty is technically feasible and successfully emulates the 
established principles of open enterocystoplasty while minimizing operative morbidity. As 
is true in open surgery, various bowel segments can be fashioned and anastomosed to the 
bladder laparoscopically. The increased costs associated with laparoscopy and weight 
minimally invasive surgery in general have been a significant disadvantage; however, a 
pervious report on the costs of laparoscopic procedures concluded that increased surgical 
experience reduces the surgical time and length of hospital stay, thereby decreasing costs. . 
Furthermore, the increased use of reusable instruments results in considerable economic 
benefits. Implementation of appropriate cost-saving strategies ultimately will result in 
decreased expenses associated with laparoscopy. Although laparoscopic enterocystoplasty 
is currently a lengthy procedure lasting twice as long as open surgery, further technical 
modifications and increasing experience will continue to reduce the surgical time involved. 
For patients with complex co-morbid illness who desire the improved quality of life 
associated with traditional augmentation cystoplasty, the reduced morbidity observed in the 
authors’ series of patients undergoing a laparoscopic procedure makes this approach an 
attractive option to consider. The authors’ initial experience suggests that laparoscopic 
enterocystoplasty has the potential to become a viable alternative to open enterocystoplasty. 
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